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in Partial Fulfillment of the Requirements for the 
Degree of Doctor of Philosophy 
(in Food and Nutrition Sciences) 
August, 2005 
Dietary manganese affects the structure and integrity of blood vessels, as well as 
vessel predisposition to endothelial dysfunction and cardiovascular disease. In this thesis, 
we studied the role of manganese on the functional properties of rat aorta as defined by the 
endothelial and vascular smooth muscle cell pathways for adrenergic-mediated 
vasoconstriction and cholinergic-mediated vasodilation. 
Weanling Sprague-Dawley rats were fed a manganese deficient (MnD), adequate 
(MnA-control group) or supplemented (MnS) diet (<1, 10-15 and 45-50ppm Mn 
respectively). After 14 weeks on the diet the aorta was excised and four aortic rings of 
three mm length were prepared from each animal. Alterations in vasoconstriction among 
diet groups were detected by dose-response curves to the ^-adrenergic agonist L-
Phenylephrine in endothelium-intact and endothelium-disrupted rings. Alterations in 
endothelium-dependent vasodilation among diet groups were determined by dose-
response curves to Acetylcholine. We studied the mechanism by which dietary 
manganese affects two different endothelium-dependent vasodilation pathways: the L-
arginine/nitric oxide (NO) and the cyclooxygenase (COX) pathways. Inhibition of the 
enzymes for NO synthesis (NOS) with L-NMMA, and of prostanoids (COX I and II) with 
Mefenamic acid, determination of NOS expression, and in vitro addition of L-Arginine 
(substrate for NO formation) to vessel rings revealed the effect of manganese on the 
regulation of endothelium-mediated vasodilation and vasoconstriction. Dose-response 
curves to sodium nitroprusside provided data for the dietary effect on endothelium-
independent vasodilation. 
Supplementary dietary manganese increased adrenoreceptor-mediated vascular 
smooth muscle contraction, which was significantly reduced in the presence of functional 
endothelium. Absence of dietary manganese increased endothelial cell sensitivity to the 
(Xi-adrenergic vasoconstrictor agent. Manganese had a small effect on the cGMP-pathway 
for dilation of vascular smooth muscle but affected vasodilation primarily through an 
endothelium-mediated pathway, probably by preserving NO bioavailability. Inhibition of 
vasodilation in Mn deficiency appears to occur through an endothelium-derived 
vasoconstrictor, possibly thromboxane with a concomitant decrease in the synthesis of 
endothelium-mediated vasodilator prostanoids. Our results demonstrate that dietary 
manganese influences the contractile machinery of vascular smooth muscle cells and 
regulates the bioactivity of endothelium-mediated vasodilators to affect agonist-induced 
signaling pathways that participate in the regulation of vasomotor tone. This suggests 
possibilities for dietary intervention in blood pressure regulation. 
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Chapter 1 
Manganese and Arterial Functional Properties: An Overview of the Literature 
1.1. Manganese as an Essential Trace Element 
Manganese (Mn) belongs to the group of fourteen essential trace elements and is 
named after the Greek word for "magic", which represents the wide range of metabolic 
functions and diverse pathologies that can result from either Mn deficiency or toxicity 
[Cotzias, 1958]. Manganese is present in most mammalian tissue in concentrations 
ranging from 0.3 to 2.9 u,g Mn/g of wet tissue weight and is considered to be among the 
least toxic of trace elements when administered orally [Dorman, 2001]. Manganese enters 
the body through dietary sources and through combustion of gasoline that might release 
air-borne submicron particles of Mn30"4 [Barceloux, 1999]. Food is the main source of 
Mn intake, which varies from 2-9 mg daily [Greger, 1999]. Manganese is absorbed from 
the diet in divalent and tetravalent states [Barceloux, 1999]. The bioavailability of Mn 
depends on the physiological mechanisms that regulate Mn absorption, liver metabolism, 
biliary and pancreatic excretion and this Mn bioavailability is influenced by the parallel 
intake of other nutrients [Britton & Cotzias, 1966][Davis et al., 1993][Finley & Davis, 
l999|[Maleckietal., 1996] [Papavassiliou et al., 1966][Kuratko, 1997][Johnson, 1990], 
Food is the most important source of Mn for the general population. Daily intake 
varies from 2-9 mg Mn depending on dietary habits, the consumption of high Mn-
containing foods and the Mn concentration of the soil that subsequently affects the 
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concentration of Mn in water and food [Barceloux, 1999][Patterson et al., 1984]. Rich 
dietary sources of Mn are nuts, grains, tea, legumes, fruits and vegetables. Poultry, meat, 
refined foods and dairy products comprise poor sources of the trace element [Gropper et 
a I., 2004], 
Manganese deficiency results in skeletal abnormalities in many animal species 
[Wolinsky el al., 1994|. Shortened and thickened bones with swollen and enlarged joints, 
chondrodystrophy, disturbed synthesis of organic matrix of cartilage and bone are some 
of the physical abnormalities [Tal et al., 1965|[Leach, 1971]. In Mn deficiency 
development of abnormal otoliths in the inner ear can cause ataxia and inability to control 
body-righting reactions |Freeland-Graves et al., 1994], as well as abnormalities in 
function and ultrastructure of mitochondria [Liu et al., 2002]. As the site of oxidative 
phosphorylation, mitochondria are a significant source of potentially hazardous reactive 
oxygen species and free radicals. Thus, deficiency of Mn might lead to superoxide radical 
poisoning due to the loss of manganese superoxide dismutase (Mn-SOD) activity, a Mn-
dependent antioxidant enzyme of mitochondrial origin [Liu et al., 2002][Yan et al., 
19981| Yan et al., 2001]. Clinical symptoms of experimental Mn deficiency have been 
described in two human studies. Doisey reported development of scaly transient 
dermatitis, hypocholesterolemia, depressed vitamin K-dependent clotting factors and 
reddening of hair with an accidental low Mn intake of 0.34 mg/ day in one human 
[Doisey, 1972]. In a second study, an experimental semipurified diet of 0.11 mg/day was 
consumed by seven men between the ages of 19 and 22 years for 39 days, and they 
developed a reduction in total and high density lipoprotein serum cholesterol, fine 
scaling, and miliaria crystallina which was defined as a type of erythematous rash 
2 
[Friedman et al, 1988]. In contrast, there have been no reports of gross Mn deficiencies in 
free-living populations, probably due to the abundance of Mn in the diet and the very low 
requirements for Mn [Underwood, 1981]. 
Methodological difficulties such as the lack of correlation between serum Mn and 
tissue levels, increase the difficulty in assessing and documenting Mn deficiency 
[Matsuda et al., 1989]. However, several population groups have been characterized with 
suboptimal levels of Mn. These include children with metabolic syndromes such as 
phenylketonuria, maple syrup disease, galactosemia and methylmalonic acidemia; 
children and adults with epilepsy; patients with exocrine pancreatic insufficiency, active 
rheumatoid arthritis, or hydralazine syndrome [Freeland-Graves, 1988][Dupont & 
Tanaka. 1985]. Pennington et al. [Pennington et al., 1986] have reported that mean Mn 
intakes for adolescent girls, adult and elderly women are considerably lower than the level 
presently set by the Estimated Safe and Adequate Daily Diet Intakes. Intake of Mn may 
also be compromised in the U.S. population since routine use of supplements, such as 
calcium, as well as high intakes of processed foods and refined carbohydrates might reduce 
absorption or retention of Mn [Temple, 1983], 
Manganese toxicity can be a result of acute or chronic exposure to the trace 
element due to occupational inhalation of Mn-containing particles or fumes in Mn mines 
and other industrial plants. The symptoms of Mn toxicity resemble the ones in 
Parkinson's disease and are associated with a decrease in dopamine levels in the 
dopaminergic nigrostriatal pathways [Mena, 1970][Keen, 1984]. To date, there are no 
reports of Mn toxicity in humans associated with food or water consumption. 
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1.2. The Biochemical Role of Manganese 
Manganese participates as a cofactor in the structure of several enzymes and 
modulates important signal transduction pathways (Table l.l)[Wedler, 19941. Manganese 
increases the accumulation of second messengers such as cyclic AMP (cAMP) and cyclic 
GMP (cGMP) by activating adenylate cyclase (AC) and guanylate cyclase (GC) 
respectively, which are significant diffusible effector molecules that activate proteins for 
further cell-signaling | Korc, 19931 [Keen e t ah, 1984]. Manganese might modulate in 
vitro cell-surface receptor binding and adhesion by modifying the requirement for 
specific adhesion proteins (Table 1.2.) [Edwards et ah, 1988]. The effects of Mn on 
cytoplasmic Ca+2 levels might have an indirect effect on cellular function. Increases in 
intracellular Ca+2 levels might occur with the entrance of Ca+ directly from extracellular 
sites by transmembrane diffusion, voltage dependent channels or agonist dependent 
channels [Gropper et ah, 2005]. Manganese can modulate Ca+2 homeostasis by blocking 
Ca+2 influx, by enhancing Ca+ efflux and by increasing Ca+2 flux through the 
mitochondrial uniporter [Korc, 1993J[Kwan et ah, 2003]. In addition to its role as a Ca+2 
entry blocker, Mn has been shown to enhance the autoxidation of catecholamines to 
attenuate the contractile response to norepinephrine in vitro [Kappus & Schenkman, 
19791. 
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Table 1.1. Manganese-dependent enzyme systems [adopted in part from Wedler, 1994]. 
Category 
Oxidoreductases 
Superoxide dismutase 
Catalase 
Peroxidase 
Transferases 
Galactosyl-
Glucosyl-, glycosyl-
Glucuronosyl-
Protein kinases 
(Tyr, Ser) protein kinases 
P-inositol(4-P)kinase 
Sulfo-groups 
Hydrolases 
Protein phosphatases 
P-inositol phosphatase 
Cyclic nucleotide phophodiesterase 
Metalloproteases 
Arginase 
Lyases 
PEP carboxykinase 
Adenylate cyclase 
Guanylate cyclase 
Ligases 
Glutamine synthetase 
Pyruvate carboxylase 
AA-tRNA synthetases 
Function 
O2"' acceptor 
H2 O2 acceptor 
H2 O2 acceptor 
Glycosyl groups 
Glycosyl groups 
Glycosyl groups 
P-containing -OH acceptor 
P-containing -OH acceptor 
P-containing -OH acceptor 
S-containing 
P-monoesters 
P-monoesters 
P-diesters 
Peptide bonds 
Amidines 
C-C bonds 
P-0 bonds 
P-0 bonds 
C-N bonds 
C-C bonds 
C-0 bonds 
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Manganese is an essential component of several metalloproteins such as pyruvate 
carboxylase and glutamine synthetase. The role of Mn in glucose metabolism has not yet 
been clearly established even though it appears to be the preferred divalent cation for 
activation of the protein tyrosine kinase activity of the insulin receptor [Rosen & 
Lebwohl, 1988). Manganese is also a co-factor for enzyme systems such as xanthine 
oxidase, calmodulin-dependent protein phosphatase, hexokinase, arginase and superoxide 
dismutase [Wedler, 1994][Korc, 1993][Weisiger et al., 1973]. MnSOD plays a dominant 
role in protecting cells from oxidative stress by catalyzing the reaction of superoxide 
radical to hydrogen peroxide, a less reactive oxygen species. MnSOD requires Mn as a 
transition metal co-factor. Thus, MnSOD activity might be controlled through availability 
of Mn. Hence, the antioxidant effect of Mn can be attributed to a large extent to the role 
of Mn as a cofactor of MnSOD, whose activity is directly related to the nutritional status 
of Mn [Fernandes et al., 1988j[Malecki & Greger, 1996]. 
Special interest has been focused lately on arginase, a regulatory enzyme that is 
allosterically activated by Mn and has the potential of regulating the availability of L-
arginine for nitric oxide (NO) synthesis, an endothelium-derived vasodilator. Rat aortic 
endothelial cells express two types of arginases (I and II) with different subcellular 
localization. Altered arginase activity could limit the availability of L-arginine for NO 
synthesis in intact cells [Wu & Morris, 1998]. Severe Mn deficiency reduces arginase 
activity, which implicates that Mn might affect NO production and/or bioavailability. 
The diffusion of NO from the endothelial cell to the vascular smooth muscle cell leads 
to activation of soluble guanylate cyclase (sGC), a metalloenzyme that prefers Mn+2 over 
Mg+ as a cofactor to support its catalytic activity [Lucas et al., 2000]. Nitric oxide binds 
6 
directly to the heme component of sGC to form a ferrous-nitrosyl-heme complex [Nighorn, 
1999]. Cyclic GMP is formed from GTP, which induces smooth muscle relaxation by 
reducing intracellular Ca+2 and desensitizing the contractile apparatus to Ca+ . The precise 
mechanism by which Mn2+ allosterically modulates guanylyl cyclase activity remains unclear. 
The skeletal and structural abnormalities that are observed in Mn deficiency are 
due to the decreased activity or expression of Mn-dependent enzymes that participate in 
mucopolysaccharide synthesis. These enzymes include UDP-xylosyltransferase, 
glycosyltransferases, galactosyltransferases I and II and polymerase, which mediate the 
synthesis and sulfation pattern of chondroitin sulfate [Leach, 1969][McNatt et al., 
I976|| Yang & Klimis-Tavantzis, 1998][Yang & Klimis-Tavantzis, 1998b]. Manganese 
seems to affect not only the concentration but also the sulfation pattern and disaccharide 
composition of aortic heparan sulfate glycosaminoglycans [Kalea et al., 20041. The 
sulfation of proteoglycan molecules might affect the clustering and thus the activation of 
cellular receptors [McDonnel et al., 2004], 
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Table 1.2. Receptor-Manganese Interactions [adopted in part from Wedler, 1994], 
Receptors 
Acetylcholine 
Adrenergic 
Cholinergic 
Dopaminergic 
Fibronectin 
Insulin 
Manose-6-P 
Muscarinic 
Opioid 
Oxytocin 
Platelet GPIIb/IIIa 
Serotonin 
Tachykinin 
Vasopressin 
1.3. Endothelial Function and Dysfunction 
During the past two decades medical research has increasingly focused on the 
relationship between endothelial function and the different stages of various 
cardiovascular diseases. The endothelial cell layer is the largest endocrine organ in the 
body since the endothelium lines the vascular lumen throughout the cardiovascular 
system. The endothelium forms an interface between tissues and circulating blood, which 
provides oxygen, nutrients and hormones and removes carbon dioxide and other 
metabolic waste products [van Hinsbergh et al., 2002]. The diverse biological roles of 
endothelium include regulation of vasomotor tone, cellular permeability, intravascular 
homeostasis, platelet aggregation, monocyte adhesion, vascular smooth muscle growth 
and blood coagulation [Matsuoka, 2001]. 
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Endothelial modulation of vascular tone is mediated primarily through the 
production and release of endothelium-derived vasoactive modulators that affect directly 
or indirectly the contractile machinery of the vascular smooth muscle [Ltischer & 
Vanhoutte, 1990]. These endothelial modulators are divided into two classes: the 
endothelium-derived relaxing factors (EDRFs) and the endothelium-derived contracting 
factors (EDCFs). Nitric oxide (NO), prostacyclin and endothelium-derived 
hyperpolarizing factor (EDHF) are major relaxing factors that cause dilation of vascular 
smooth muscle. Endothelin-1, thromboxane, prostaglandin H2, catecholamines and 
angiotensin II are major contracting factors. However, a complete list of all EDRFs and 
EDCFs still remains unknown. 
Endothelial dysfunction is a hallmark of atherosclerosis and is characterized by an 
imbalance between the EDRFs and EDCFs that precedes the early manifestations and 
angiographic detection of cardiovascular disease [Vogel, 1997J. Endothelial cells in the 
intimal layer of the blood vessel wall recognize the presence of vasoactive substances 
such as acetylcholine, adenosine di- and tri-phosphate, histamine, bradykinin and 
norepinephrine to generate signals that modify the contractile machinery of the smooth 
muscle cells in the media layer [Vanhoutte, 1981]. One major cause of endothelial 
dysfunction is oxidative stress, which results from abnormalities in the mitochondrial 
respiratory chain or in the coupling of oxidative phosphorylation [Matsuoka, 2001]. The 
superoxide anion is reduced to hydrogen peroxide via dismutation and transition metal-
catalyzed reactions lead to the production of highly reactive hydroxyl radicals from 
hydrogen peroxide (Figure 1.1). Reactive oxygen species interact with endogenous 
vasoactive mediators and modulate vascular tone and the atherogenic process [Arnal et 
9 
al., 1999]. Superoxide reacts rapidly with nitric oxide to inactivate it. Oxidative stress 
also reduces the endogenous synthesis of endothelial nitric oxide synthase (eNOS or NOS 
III), the enzyme that catalyzes the formation of NO from L-arginine [Wang et al., 2000], 
Figure 1.1. Generation of Reactive Oxygen Species. 
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The ro]e of the endothelium as a protagonist in vascular homeostasis is evidenced 
by the fact that disease conditions such as essential hypertension, atherosclerosis and 
diabetes involve an impaired production or bioavailability of endothelium-derived 
mediators [Rubanyi, 1988][MnIntyre et al., 1997][De Vriese et al, 2000]. The exposure to 
coronary risk factors decreases the bioactivity to EDRFs and increases the release of 
EDCFs. Aging, prolonged exposure to shear stress and lifestyle-related risk factors such 
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as obesity, diabetes, hypertension, smoking and poor dietary habits can accelerate the 
turn over and apoptotic death of endothelial cells to give abnormal endothelial function 
[Luscher & Vanhoutte, 19901. In these cases, endothelial cells are not effective in 
producing bioavailable NO while the production of endothelium-derived vasoconstrictors 
is upregulated. These vasoconstrictors (usually eicosanoids), as well as oxidative 
lipoproteins and growth factors lead to the initiation of the atherosclerotic process and the 
characteristic morphological changes in the structure of the vessels. 
1.3.1. Vasoconstriction and Vasodilation Pathways 
Vascular smooth muscle contraction is described by the sliding-filament model 
that applies in all muscle contractions (smooth, skeletal and cardiac muscles). Within the 
sarcoplasm of the muscle cell there are subcellular elements and long prominent 
myofibrils, composed of bundles of contractile proteins. Each myofibril has many short 
structural units, known as sarcomeres, which are composed mostly of actin thin filaments 
and myosin thick filaments. Sarcomeres represent the minimal contractile unit of a 
muscle. Tropomyosin, a contractile accessory protein, covers the myosin binding sites on 
actin, inhibiting interaction of actin with myosin. The appearance of Ca+2 in the 
sarcoplasm leads to Ca+ binding on troponin-C, a second contractile accessory protein, 
which moves the attached tropomyosin molecule deep into actin, uncovering the myosin 
binding sites on actin subunits. The exposed sites are then available to interact with 
myosin headpieces. When Ca+2 is removed from sarcoplasm the conformational states of 
troponin and tropomyosin prevent the actin-myosin interaction and lead to the relaxed 
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state. Actin and myosin filaments as well as the accessory proteins compose the 
contractile machinery of the vascular smooth muscle (Figure 1.2). 
Figure 1.2. Relaxed (a) and Contracted (b) Contractile machinery (adopted by 
www.physioweb.org). 
Sarcomere after e<MvlracUon 
Vascular constriction and dilation are the result of vascular smooth muscle 
response to mediators that are circulating in the blood or are produced by the endothelial 
cell layer on vascular innervations. Endothelium-dependent vasodilation has been 
demonstrated in various vascular preparations in response to stimuli such as 
acetylcholine, bradykinin, histamine, adenine nucleotides, thrombin, substance P, Ca+ 
ionophores and increased blood flow [Moncada et al., 1991]. The major EDRF, which 
induces vasodilation is NO [Furchgott & Zawadzki, 1980], this highly reactive and 
diffusible free radical which produces vasodilation via the activation of soluble guanylate 
cyclase (sGC) and elevation of cGMP [Liischer & Vanhoutte, 1990]. Cyclic GMP 
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induces vascular relaxation by increasing Ca+ efflux, decreasing the amount of Ca+" 
released from intracellular stores, activating a protein kinase which stimulates cAMP-
dependent Ca+2 extrusion across the vascular smooth muscle sarcolemma, and by 
inhibiting the breakdown of phosphatidyl-inositol in vascular smooth muscle [Luscher & 
Vanhoutte, 1990]. Nitric oxide diffuses in the smooth muscle but also into the lumen of 
blood vessels to affect the permeability of the endothelial cells to macromolecules. 
Following the identification of NO as EDRF, scientific research has focused on the role 
of NO for the regulation of vasomotor tone, platelet aggregation, platelet and leukocyte 
adhesion, and vascular smooth muscle cell proliferation [Venema et al., 1999]. 
Binding of a ligand to its receptor in the endothelial cell activates the receptor and 
initiates a signaling cascade of events, which usually involves the interaction of several 
different enzyme systems. This activation induces an influx of Ca+2 into the cytoplasm of 
the endothelial cell which binds to calmodulin to activate cyclooxygenase and nitric 
oxide synthase, and lead to the release of EDHF (Figure 1.3.) [Vanhoutte, 2003]. Nitric 
oxide diffuses to the smooth muscle to increase the formation of cGMP from GTP. 
Endothelium-derived hyperpolarizing factor (EDHF) causes hyperpolarization by 
opening K+ channels, and prostacyclin (PGI2) activates adenylate cyclase (AC), which 
leads to the formation of cAMP. All of the above functions lead to vasodilation [Luscher 
& Vanhoutte, 1990]. The contribution of hyperpolarization to endothelium-dependent 
vasodilation varies depending on the type of the vessel. Even though in large arteries, NO 
predominates under normal conditions, EDHF can mediate near normal levels of 
vasodilation when the endothelium is inhibited or is dysfunctional [Vanhoutte, 2003], 
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Figure 1.3. Vasoconstriction and vasodilation in endothelial and smooth muscle cell. 
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Adrenergic receptors are a heterogenous group of seven transmembrane 
domains/G-protein coupled receptors that mediate the actions of the natural adrenergic 
amines epinephrine and norepinephrine [Garcfa-Sainz, 2000]. The ai adrenoreceptors 
stimulate phospholipase C activity, which catalyses the hydrolysis of phosphatidylinositol 
4,5-biphosphate (PIP2) to diacylglycerol (DAG) and inositol 1,4,5,-triphosphate (IP3). 
Diacylglycerol mediates the activation of protein kinase C and IP3 acts a second 
messenger to mediate the release of intracellular calcium (Figure 1.4.) [Krauss, 2001]. 
The function of the receptor might be affected by cellular processes that alter its 
internalization, phosphorylation, degradation, regulation of expression or its binding to 
the ligands, such as the adrenergic agonist. Activation of the receptor leads to 
mobilization of intracellular calcium and takes place via two different mechanisms: Ca+2 
influx through Ca+2 permeable channels and Ca+2 release from intracellular Ca+2 stores. 
Nitric oxide diffuses to the smooth muscle and acts through a cGMP-dependent protein 
kinase to control the phosphorylation and dephosphorylation of the myosin light chains 
(Figure 1.4.) [Luscher & Vanhoutte, 1990]. 
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Figure 1.4. Endothelium-dependent vasodilation pathways. 
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1.3.2. Nitric Oxide 
Mammalian tissues and various cell types, including the vascular cells, synthesize 
NO from L-arginine through a five-electron oxidation step (Figure 1.5). The substrates of 
NOS-mediated NO production are the amino acid L-arginine, molecular oxygen and 
NADPH [Michel et al., 1997J. The oxidation of L-arginine is catalyzed by a cytochrome 
P450-type heme iron in the oxygenase domain of NOS. The electrons required for 
reduction of O2 are shuttled from the cofactor NADPH to the heme, via a flavin-
containing cytochrome P450 reductase that forms the C-terminal half of the NOS protein. 
Thus, cofactors that are required for NO generation are tetrahydrobiopterin (BH4), flavin 
adenine dinucleotide (FAD) and flavin mononucleotide (FMN). This electron transport 
chain only operates when Ca+ /calmodulin is bound to the enzyme, which provides the 
Ca+" regulation of endothelial NO synthesis [Mayer et al, 1998]. At low concentrations of 
L-arginine or in its absence, the enzymatic reduction of O2 uncouples from substrate 
oxidation and results in the generation of superoxide anions and H2O2. 
Figure 1.5. Nitric oxide generation from L-Arginine. 
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There are three isoforms of NOS which catalyze the formation of L-citrulline 
from L-arginine with the formation of NO: neuronal NOS (nNOS or NOS I) and 
endothelial NOS (eNOS or NOS III) which are constitutively expressed at low levels in a 
variety of cell types, and inducible NOS (iNOS or NOS II) which normally is not 
expressed in most cell types but can be induced for example by bacterial endotoxin and 
inflammatory cytokines [Wu & Morris, 1998]. NOS I and III are dynamically regulated 
by Ca+2/calmodulin, while arginine serves as a substrate and acts structurally to facilitate 
the dimerization of NOS. Endothelial NOS is associated with caveolae at localized 
regions of the plasma membrane, and contains binding sites for heme and calmodulin, 
both being essential for enzyme activity. After Ca-loaded calmodulin is bound to NOS III 
between the C-terminal reductase and N-terminal oxygenase domain of NOS III, 
electrons are shuttled through the calmodulin-binding domain toward the heme-
containing NOS III oxygenase domain, which results in the formation of citrulline and 
NO |Covers, 2001 J. Unlike many other signaling molecules, -NO is freely diffusible, 
reacts with a diverse array of intracellular targets, and manifests biological effects that are 
dependent on the local chemical environment. Nitric oxide is a small lipophilic molecule 
with a biological half-life of several seconds; Thus, it can easily diffuse into and across 
plasma membranes and lipoproteins. 
As a free radical, -NO readily reacts with other radical species and the metal 
centers of metalloproteins [Bloodsworth, 2000], The metal-binding action of -NO to the 
heme iron of soluble guanylate cyclace (sGC) in the vascular smooth muscle cells 
stimulates the production of cGMP, which activates cGMP-dependent kinases and 
membrane ion channels to decrease intracellular calcium levels and allow smooth muscle 
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cells to relax. Thus, nitric oxide has profound cardiovascular effects, including the 
regulation of blood pressure. Compounds such as nitroglycerine and sodium nitroprusside 
imitate an endogenous nitrovasodilatory system by being converted to nitric oxide 
IMoncada et al, 1993]. The biologic effects of NO include its role as a potent vasodilator, 
neurotransmitter and cell-signaling effector molecule, but also include effects to increase 
vascular permeability, mediate immune responses and inhibit platelet aggregation. 
1.4. Manganese and Regulation of Vasomotor Tone 
It has been reported that Mn deficiency causes ultrastructural changes in the 
arterial wall, such as alterations in integrity of cell membranes, swollen and irregular 
endoplasmic reticulum, elongated mitochondria with crystal structures, and enlarged and 
abnormal Golgi apparatus [Freeland-Graves, 1994]. Previous studies from our laboratory 
have reported that Mn interferes in the metabolism of glycosaminoglycans, proteoglycan 
molecules that participate in the structure of the cell membrane LYang et al, 1998a][Yang 
et al, 1998b|[Ekanayake et al, 1995][Kalea et al, 2004]. Manganese is essential for 
preventing surface damage of the aorta and maintaining the density of the extracellular 
matrix around smooth muscle cells, especially in the medial layer [Yang et al, 1998]. 
Transmission electron microscopy of the arterial wall shows less dense extracellular matrix 
around smooth muscle cells, especially in the medial layers of Mn-deficient rats to suggest 
the possibility of changes in endothelial and/or vascular smooth muscle cells, which could 
affect the contractile properties of arteries [Ekanayake et al, 1995]. Manganese is involved 
in arterial glycosaminoglycan (GAG) metabolism by affecting the total proteoglycan content 
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of the aorta, and by altering the molecular weight and sulfation pattern of chondroitin sulfate 
in the same tissue [Yang et al, 1998a][Yang et al, 1998b]. In addition, Mn concentration in 
the diet affects the heparan sulfate sulfation pattern and disaccharide composition in 
Sprague-Dawley rats to suggest the possibility of Mn-mediated alterations in cellular signal 
transduction pathways [Kalea et al, 2004]. Changes in vascular GAG molecules might 
predispose vessels to lipid deposition, lipoprotein oxidation and cardiovascular disease. 
Animals deficient in Mn have decreased activity of MnSOD in the heart, liver and 
kidney [Ensunsa et al, 2004][Malecki et al, 1994][Malecki et al, 1996]. However, there are 
no studies to our knowledge on the MnSOD activity in vascular tissue. If MnSOD activity is 
reduced in vascular tissue, which is possible in severe Mn deficiency, we would expect a 
compromised antioxidant defense system in the vascular cell with possible increase in 
oxidative stress. An increase in the production of superoxide anions would reduce the 
bioavailability of NO and increase the production of its by-products (peroxynitrite ONOO-, 
nitrite NO2 and nitrate and NO3), which could affect cell-signaling pathways for vasodilation 
IGaoetal, 1994][Harris et al, 1995][Williams et al, 1998][Matsuokaet al, 2001]. 
There have been several studies on the in vitro effect of different acutely-applied 
concentrations of Mn on contraction of different vascular beds [Deth et al, 
1981][Kunbayashi, 1969][Sullivan et al, 1968][Yan et al, 1998][Hoffman et al, 
198i][Collins et al, 1972][Weiss et al, 1985], but the effect of dietary Mn on the 
functional properties of the arteries as described by vascular contraction and relaxation 
has not previously been studied. The in vitro effect of Mn on vascular contraction is 
related to the role of Mn on calcium transport mechanisms. The divalent structure of Mn 
enables it to compete with Ca+2 for binding anionic sites and to inhibit Ca transport [Deth 
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et al, 1981][Kuribayashi, 1969][Sullivan et al, 1968][Yan et al, I998][Hoffman et al. 
1981 HCollins et al, 1972J[Weiss et al, 1985). Kasten et al. [Kasten et al, 1994] have 
reported that the addition of Mn in vitro potentiates NO-induced vasodilation, while a 
recent study [Ensunsa et al, 2004] has reported that the elimination of Mn from the diet 
enhances endothelium-mediated vasodilation. It has been suggested that severe Mn 
deficiency leads to lower activity of arginase and thus reduced competition with the 
endothelial NOS for L-arginine, the substrate that forms NO [Ensunsa et al, 2004]. 
Overall, the effect of different dietary Mn levels on vasodilator and vasoconstriction 
mechanisms are unclear. 
In the normal state, the endothelium plays a major role in vascular homeostasis by 
regulating smooth muscle tone via potent vasoactive agents (NO, PGI2 , EDHF, epinephrine, 
endothelin and thromboxane). We do know that chronic exposures to several modulatory 
influences can upregulate the release of endothelium derived relaxing factors to affect 
biomechanical properties of the arteries. Such influences include exercise, estrogens, increases 
in blood flow and dietary factors such as consumption of unsaturated fatty acids, red wine 
polyphenols and other antioxidants [Vanhoutte 2003][Mombouli et al., 1996]. Dietary factors 
such as Mn intake could also affect vascular function. Taking into consideration the 
multifunctional role of Mn as an essential cofactor in many enzyme systems as well as its 
effect on vascular structure, we hypothesize that Mn intake might affect the biomechanical 
properties of the arteries ex vivo as defined by the constriction and dilation of the vascular 
smooth muscle to various agonists. 
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1.5. Objectives and Significance of the Study 
The goal of the present study was to explore the effect of dietary Mn on the 
biomechanical properties of the rat aorta through diets containing different Mn 
concentrations. 
The objectives of this study were to determine the effect of various dietary 
concentrations of Mn on: 
1. Endothelium-dependent and endothelium-independent vascular contraction as 
described by maximum force of contraction and vessel sensitivity in response to the al 
adrenergic agonist L-Phenylephrine in intact and endothelium disrupted aortic rings. 
2. Endothelium-dependent and endothelium-independent vascular dilation as 
described by maximum relaxation and vessel sensitivity in response to the endothelium-
dependent muscarinic agonist Acetylcholine and to the endothelium-independent nitric 
oxide donor Sodium Nitroprusside in intact aortic rings. 
3. Endothelium-dependent vasodilation by inhibiting nitric oxide (NO) production 
(L-NMMA), by stimulating NO production through increased L-arginine substrate and by 
inhibiting the cyclooxygenase pathway (Mefenamic acid). 
4. The expression of the two NOS isoforms (NOS II and III). 
There have been no ex vivo studies to date on the effect of dietary Mn on both the 
vasoconstrictor and vasodilation pathways as related to regulation of vasomotor tone, 
vascular function, blood pressure and cardiovascular disease. Present knowledge comes 
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from studies on the structural effect of Mn on glycosaminoglycan structure of the rat 
aorta, which participate in several cell-signaling pathways by affecting the binding of 
ligands to receptors. There have been only a few recently published studies on the in vitro 
effect of Mn on constriction of vascular tissue but these have only limited information on 
the effect of Mn on NO-mediated vasodilation in rat aorta. In the present study we 
documented the effect of dietary Mn on several key effectors that participate in the cell 
signaling pathways for vasoconstriction and vasodilation. 
Vascular ring studies are considered to be a broadly accepted way to study the 
role of the endothelium in vasomotor control and the effect of endothelial dysfunction on 
the biomechanical properties of the arteries, since in most cases the results match the 
observations in isolated human blood vessels [Vanhoutte, 1999]. Chapter 2 of this 
dissertation addresses the first objective and discusses how Mn affects adrenergic 
receptor mediated vasoconstriction. Chapter 3 addresses the second objective regarding 
the role of Mn on vasodilation pathways, and chapter 4 addresses the third and fourth 
objectives i.e. the effect of Mn on several pathways that are involved in vasodilation. 
Chapter 5 gives a summary of the results, the overall conclusions of the study and 
recommendations for future work. 
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Chapter 2 
The Effect of Dietary Manganese on Endothelium-Dependent and 
Endothelium-Independent Receptor Mediated Vasoconstriction 
In the present study we examined the effect of dietary manganese (Mn) on the 
vascular contractile machinery of rat thoracic aortas. Weanling male Sprague-Dawley 
rats were fed either a manganese deficient (MnD), adequate (MnA/ Control group) or 
supplemented (MnS) diet (<1, 10-15 and 45-50 ppm Mn respectively). After 15 weeks on 
the diet the rats were sacrificed and four aortic rings of 3 mm length were prepared. In 
two of the four aortic ring preparations the endothelial layer was mechanically disrupted 
while in the other two rings the endothelial layer was left intact. All aortic preparations 
were contracted by six cumulative doses of the cti adrenergic receptor agonist L-
-8 -6 
Phenylephrine (L-Phe, 10 to 3 x 10 M) under 1.5gm preload and were relaxed with 
-6 
one dose of Acetylcholine (Ach, 3 x 10 M) to confirm functional endothelium. The 
maximal force (Fmax) of contraction (vessel reactivity), as well as the vessel sensitivity 
(pD2) to the adrenergic agonist were determined. Manganese deficiency, assessed by 
hepatic Mn content, significantly lowered the rate of animal growth. 
In endothelium-disrupted rings, the Fmax of MnD animals was significantly 
lower than the Fmax of the MnA animals, while the Fmax of the MnS animals was 
significantly higher than the Fmax of MnA animals. In contrast, there were no 
statistically significant differences in vessel sensitivity (pD2) of endothelium-disrupted 
rings among diet groups. These data indicate that Mn has relatively little effect on 
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membrane-related receptor-mediated mechanisms (no pD2 effect) but does act to enhance 
intracellular vascular smooth muscle mechanisms at the level of the contractile 
machinery (Fmax effect). 
In the endothelium-intact rings, MnS animals developed lower Fmax when 
contracted with L-Phe compared to the MnA animals (p<0.001); however the vessel 
sensitivity (pD ) of the MnS animals to the adrenergic receptor was not significantly 
different from the MnA animals. This suggests that Mn acts to increase an endothelium-
derived relaxing factor on the contractile machinery, in order to blunt the Phe-induced 
contraction of vascular smooth muscle cells in MnS groups. Thus, dietary Mn at levels 
45-50 ppm affects the contractile machinery by reducing maximal vessel contraction to 
an ai adrenergic agonist but appears to have little effect on membrane-related signal-
transduction mechanisms. The Fmax in the MnD animals was not significantly different 
from MnA animals; however there was a significantly greater vessel sensitivity (/?D2) of 
the MnD group aortic rings to L-Phe when compared to the MnA/ Control group 
(p<0.001). This suggests that there is smaller release or smaller effect of an endothelium-
derived relaxing factor to give less (greater Fmax) blunting of the Phe-induced 
contraction of vascular smooth muscle cells in the MnD group. These data also suggest 
that there is a release of an endothelial factor to increase the sensitivity (pD ) of 
membrane-related responses to the ai-adrenergic receptor activation in the MnD group. 
Our results demonstrate for the first time that dietary Mn influences the receptor 
signaling pathways and contractile machinery of vascular smooth muscle cells in 
response to an ai adrenergic receptor agonist. 
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2.1 Introduction 
The crucial role of nutrition on the genesis and progress of cardiovascular disease 
(CVD) has been studied extensively, since cardiovascular disease still remains the 
primary cause of death in the U.S. population [American Heart Association report, 2003J. 
Trace minerals and among them Mn, may be potential risk factors for cardiovascular 
events, that cause and/or promote its development since it seems to participate in cell 
signal transduction pathways which in turn seem to affect the biomechanical properties of 
the vessels. The vascular endothelium mediates the relationship between cardiovascular 
risk factors and development of cardiovascular disease [Vogel, 1997][Vanhoutte, 2003J. 
Endothelial dysfunction is described as a condition where the endothelial release of relaxing 
factors is reduced and the secretion of contracting mediators is enhanced [Vanhoutte, 2002], 
The role of endothelial dysfunction in hypertension, arteriosclerosis, and vascular diseases 
depends on a balance between the above factors [Russo et al, 2002J[Cai et al, 
2000][Shimokawa, 1999][John et al, 2000]. These vasoactive mediators are implicated in 
early inflammation and are known to promote or inhibit vasodilation, vasoconstriction, 
blood coagulation, thrombogenesis, thrombolysis, as well as endothelial cell growth and 
remodeling [Gao et al, 1994][Nilius et al, 200I][Boulanger et al, 1999][Mombouli et al, 
1999]. Thus, an alteration in the biomechanical properties of the vascular system might 
affect not only blood flow, but also platelet aggregation and vessel permeability, 
processes that participate in the early stages of atherosclerosis and have been associated 
with hypertension, atherosclerosis and several cardiovascular disorders [Van Poppele et 
al, 2001|[Drexler et al, 1999][Harris et al, 1995][Abeywardena et al, 2002][Chamiot-
Clercetal, 1999]. 
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Several trace elements such as zinc, copper, selenium, magnesium, manganese 
(Mn), nickel, molybdenum and calcium are reported to affect the process of 
cardiovascular disease [Liu et al, 2002][Yan et al, 1998J[Yan et al, 2001] by interacting 
with ion channels, neurotransmitters, receptors and/or ionic channel-receptor complexes 
[Nilius ct al, 2001]. Previous studies have shown that Mn may affect blood pressure by 
decreasing the tension of isolated vascular tissue preparations in vitro (Kasten et al, 
1994]. However, there have been few animal studies to associate the dietary deprivation 
of Mn with cardiovascular activity in vivo or ex vivo [Ensunsa et al, 2005]. 
Our laboratory was the first to report that Mn plays an important role in maintaining 
the integrity of blood vessels [Taylor et al, 1997J[Klimis-Tavantzis et al, 1993]|_Yang et al, 
1998][Yang et al, 1998b][Ekanayake et al, 1995]. Manganese is involved in arterial 
glycosaminoglycan metabolism and affects the total proteoglycan content of the aorta, alters 
the molecular weight and sulfation pattern of chondroitin and heparan sulfate in the same 
tissue, thus predisposes the vessel to lipid deposition, lipoprotein oxidation and 
cardiovascular disease [Kalea et al, 2005][Yang et al, 1998][Yang et al, 1998b]. Manganese 
is essential for preventing surface damage of the aorta and maintaining the density of the 
extracellular matrix around smooth muscle cells, especially in the medial layer [Ekanayake 
et al, 1995J. Transmission electron microscopy of the arterial wall revealed less dense 
extracellular matrix around smooth muscle cells, especially in the medial layers of the MnD 
rats, suggesting possible changes in the endothelial and/or vascular smooth muscle cells, 
which affect the contractile properties of the arteries [Yang et al, 1998] [Yang et al, 1998b]. 
Vascular ring studies in animals are considered to be a broadly accepted way to 
experiment on the role of the endothelium in the vasomotor control and on the effect of 
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endothelial dysfunction on the biomechanical properties of the arteries, since in most 
cases the results match the observations in isolated human blood vessels [Vanhoutte, 
1999]. Our knowledge on the role of Mn on arterial wall structure and the contractile 
properties of the arteries is limited and remains to be established. There have been no 
studies in the past on the effect of different concentrations of dietary Mn on the vascular 
contractile properties. In our study we examined the role of dietary Mn on arterial 
functional properties and on receptor sensitivity of Sprague-Dawley rat aortic rings, in the 
presence and in the absence of the endothelial layer, as assessed by aortic smooth muscle 
contraction in response to Phe, an cii adrenergic agonist. 
2. 2. Materials and Methods 
2.2.1. Animal Model 
Thirty weanling male Sprague-Dawley rats (Charles River Laboratories, 
Wilmington, MA) were randomly assigned to three groups of ten rats, each on a Mn 
deficient (MnD), Mn adequate (MnA) and Mn supplemented (MnS) diet with <lppm, 10-
15ppm and 45-50 ppm of Mn respectively. The above Mn levels were chosen because 
studies indicate that a Mn level of less than 1.0 ppm results in Mn deficiency in about 
thirteen to fifteen weeks [Taylor et al, 1997][Klimis-Tavantzis et al, 1993][Yang et al, 
J 9981| Yang et al, 1998b]. Ten ppm dietary Mn levels have been reported by the American 
Institute of Nutrition as an adequate level to prevent deficiency in the rat [Reeves et al, 
1993], thus MnA diet group was used as a Control group. The animals were individually 
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housed in metal mesh-bottomed cages in an environmentally controlled room maintained at 
22°C with a 12:12 hrs light:dark cycle. All animals were weighed weekly. The Animal Care 
and Use Committee of the University of Maine approved all animal care and 
experimental procedures. 
2.2.2. Diets 
Diets were mixed in our laboratory from purified ingredients (Table 2.1), as 
described before LYang et al, 1998J[Yang et al, 1998b]. Vitamin (A.O.A.C. Special 
Vitamin Mixture, Harlan Tekland) and mineral mixes (ICN Biochemicals, Cleveland, 
OH) were commercially prepared. Manganese content of the diets and tap water were 
determined by atomic absorption spectroscopy at the Maine Forest and Agriculture 
Experiment Station Analytical Laboratory, Plant and Soil Department of the University 
of Maine (detection limit 0.01 ppm). Diet content of Mn was tested every time following 
diet preparation. Food consumption was measured daily in all animal groups. Tap water 
(below the detection limit for Mn) and food was provided ad libitum. 
2.2.3. Tissue sampling 
At the end of the feeding period, rat food was withheld for 12-14 hrs. Animals 
were anesthetized in a chamber with 95% CO2 / 5% O2, for approximately 2 min. 
Thoracic aortas and livers were removed carefully and washed with physiologic salt 
solution (PSS, with composition in mmol/L: NaCl, 118, KC1, 4.7, NaHC03, 25, KH2P04, 
1.18, MgS04, 1.17, Dextrose, 11, CaCl2, 1.25). Liver and kidney tissues were weighted, 
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lyophilized, pulverized and analyzed for Mn content using an atomic absorption 
spectrophotometer with a graphite furnace atomizer at the Maine Forest and Agriculture 
Experiment Station Analytical Laboratory, Plant and Soil Department of the University 
of Maine. 
2.2.4. Vascular Ring Studies 
2.2.4.1. Aortic Preparations 
The thoracic aorta was removed and submerged in a petri dish filled with 
physiologic salt solution (PSS) at room temperature. The aortic segment was cleaned of 
adherent fat and of connective tissues and four rings of 3 mm length were prepared from 
the middle part of the vessel. Two of the four rings were left intact and the other two 
were disrupted from the endothelial cell layer as described below (2.2.4.2). Two stainless 
steel wire triangles (0.012in diameter) were passed carefully through each ring. Each 
aortic ring was mounted in a 20ml Radnotti tissue bath, which contained PSS maintained 
at 37°C by a thermoregulated water circuit and was continuously bubbled with a 95% O2 
and 5% CO? mixture in order to keep the pH at 7.4. The aortic ring was attached through 
the one triangle to a fixed glass hook in the tissue bath and through the other triangle to a 
force transducer, which was connected to a tissue force analyzer (Model 410, MicroMed, 
Louisville, KY) for the measurement of isometric force. Changes in force were 
continuously displayed and recorded on a personal computer through the use of a system 
integrator software program (DMSI-210 Version 1.01, MicroMed). 
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2.2.4,2. Mechanical Disruption of the Endothelial Cell Layer 
Endothelial disruption was obtained in two of the four aortic rings from each 
animal by gentle rubbing of the aortic intima as described previously by Vanhoutte 
ILuschcr & Vanhoutte, 1990J. The aortic ring was rolled smoothly with the curved tips of 
a stainless steel forceps on a PSS saturated paper towel as shown in Figure 2.1. 
Figure 2.1. Mechanical disruption of the endothelium. 
2.2.4.3. Experimental Protocol 
A total of 120 intact rings (60 intact and 60 endothelium disrupted aortic rings 
from each diet group, ten animals in each diet group) were used to study the receptor-
mediated vasoconstriction. Resting tension (preload) was adjusted to 1.5g, since this 
preload provides the optimum concentration-response relationships to a variety of 
agonists, including the ai adrenergic receptor selective agonist L-Phe [Angus et al, 
2000J[Asbun-Bqjalil et al, 2002][Adeagbo et al, 1993][Beach et al, 2001][Kawabe et al, 
20031. Tissues were allowed to equilibrate for 60min. During this time, all rings were 
washed three times with aerated PSS (37°C, pH 7.4) and were precontracted for lOmin 
o o 
with one dose of L-Phe (10" M) and one dose of Ach (10 M), in order to eliminate non-
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specific tissue binding for the agonists. At the completion of this preconditioning dose the 
rings were washed four times for 20min with aerated PSS and the tension (preload) was 
corrected to the original baseline levels and remained unchanged throughout the 
experiment. 
Each ring was contracted with cumulative applications of six concentrations of L-
Phe (in 3 X steps) over the range (10s to 3 x 10"6 M) as it has been described before 
[Kalea el al, 2005J. A drug-tissue contact time of six minutes was allowed for each L-Phe 
concentration to achieve the maximum contraction. The presence of viable endothelium 
was assessed in all preparations by determining the ability of Ach (Ach, 3 x 10"6 M) to 
induce more than 70% of vasodilation in the presence of L-Phe. Rings were washed four 
times over 25 minutes with PSS (37°C, PH 7.4), after each agonist treatment, to bring 
aortic tension down to or slightly below the original preload level. A second L-Phe dose 
response curve was obtained, followed by the same dose of Ach, under the same passive 
tension (preload) in order to duplicate the contraction curve. 
2.2.5. Drugs 
Acetylcholine (Ach) chloride, L-Phenylephrine (L-Phe) and salts for the stock 
solutions of the physiologic salt solution (PSS: NaCl, KC1, NaHC03, KH2P04, MgS04, 
Dextrose, CaCb) were purchased in pure forms from Sigma-Aldrich Chemical Co (St 
Louis, MO, U.S.A.) and were dissolved in distilled water. 
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2.2.6. Statistical Analysis 
Animal body, liver and kidney weights as well as liver and kidney Mn 
concentration were compared using a one-way analysis of variance (ANOVA). The mean 
daily food intake was measured in a previous pilot experiment [Kalea AZ et al 2005J in 
which we observed no significant differences in food intake among animals from 
different diet groups. Thus, food intake was not measured in this experiment. 
In intact rings, relaxation to the Ach dose lower than 70% was an indication of 
possible damage in the endothelium during the experimental procedure and was used as a 
qualitative exclusive criterion (intact rings with >70% of Ach relaxation were excluded). 
Similarly, in endothelium-disrupted rings relaxation to the Ach dose higher than 5% was 
used as an indicator of incomplete mechanical disruption of the endothelial cell layer 
thus, these rings were also excluded. 
Contractile responses were expressed as the force derived (g) in response to the 
maximal dose of L-Phe (Fmax). Maximal contraction force (Fmax) was an indicator of 
changes in contractile machinery events such as the myosin light-chain kinase and actin-
myosin cross bridge activity [Pratt & Taylor, 1990]. Comparisons of the maximal 
contraction force (Fmax) developed in all intact and disrupted rings revealed differences 
of the contractile machinery among animals with different dietary Mn intake. Half-
maximal response (EC50) values for L-Phe were extrapolated from the dose-response 
curves. Using the EC50 data, we estimated the vessel sensitivity to L-Phe as described by 
the pDi value (pD2=-logio EC50). The pD2 values for the intact and denuded rings of all 
animals also showed differences in the vessel sensitivity to the ai adrenergic receptor 
among diet groups. 
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All results were expressed as mean values ± standard error of the mean (SEM). 
The Fmax and pD2 values to L-Phe were compared in two-way analysis of variance 
(ANOVA) tests in order to determine the effect of diets on the contractile machinery 
(Fmax) and on vessel sensitivity (pD2). Student Newman-Keuls multiple comparison 
tests were used for statistical analysis and a p-value level of 0.05 or less was considered 
as statistically significant. The Sigmastat Statistical Program Package (SAS Institute, 
Cary, NC) was used to conduct the statistical analyses. 
2.3. Results 
2.3.1. Animal Growth 
All animals fed a MnD, MnA or MnS diet gained weight. However, mean body 
weights were significantly different among all groups (Table 2.1). The rate of growth in 
Mn deficient (MnD) animals was slower compared to the Mn adequate (MnA) and Mn 
supplemented (MnS) rats (Table 2.1). The difference in growth rate was statistically 
significant starting the fourth week after the initiation of the diet as it has been reported in 
the past [Yang & Klimis, 1998a]. Kidney weights (Table 2.1) were not statistically 
significant among diet groups while liver weights of the MnD rats were reduced when 
compared to MnA. This reduction was proportionate to the total body weight reduction. 
The percentage of liver weight to body weight of the rats was not different among the diet 
groups (Table 2.1). Manganese deficiency was confirmed by hepatic and kidney Mn 
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concentration, which significantly decreased only in the MnD group (Figures 2.1 and 
2.2). 
Table 2.1. Effects of dietary Mn on body, liver and kidney weight. 
Diet Body weight Liver weight Liver weight as a % Kidney weight 
Groups (g) (g) of body weight (g) 
MnD 385 ± 11 11.46 ±0.45" 3.0 ±0.001 ~~3~45±0.10 
MnA 468 ±12 14.39 ± 0.60 3.1 ±0.001 3.50 ±0.10 
MnS 474 ±11* 14.00 ±0.55* 3.0 ±0.001 3.68 ±0.08 
(*) Statistically significant differences at p<0.05 compared to MnA/ Control group. 
2. J. 2. Response to L-Phenylephrine-lnduced Vasoconstriction 
Six cumulative doses of L-Phe were used to give concentrations of 10"8, 3 x 10"8, 
10"7, 3 x 10" , 10" and 3 x 10"6 M in the tissue baths to produce graded increases in 
concentration force. The maximum contraction force developed in response to L-Phe was 
observed at drug doses higher than 10"6 M (5th and 6th L-Phe doses). Washout of agonist 
over 25 min reduced vasoconstriction at least to the preload value. 
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Figure 2.2. Hepatic Manganese Concentration among diet groups. 
7.603 
MnD MnA MnS 
(*) Statistically significant differences at /?<0.001. 
Figure 2.3. Kidney Manganese Concentration among diet groups. 
2.706 
MnD MnA MnS 
(*) Statistically significant differences at/?<0.001. 
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The decrease in tension to the 3 x 10" M Ach dose was divided by the ring 
tension just prior to the Ach dose (point after the last point of the final L-Phe dose) and 
was used to calculate a percent relaxation for that ring when the drug was applied. 
Relaxations to the one dose of Ach were expressed as percentages of the level of final 
precontraction. Application of the Ach dose at the end of the L-Phe concentration 
response curve significantly relaxed the L-Phe contracted aortic rings of all groups 
(approx. >70%) and that indicated that the endothelium was not damaged during the 
tissue extraction process and the aortic ring preparation. All endothelium-disrupted rings 
failed to relax in response to Ach (<5%). 
As expected the Fmax values in endothelium-disrupted rings was greater when 
compared to the intact Fmax values developed in each diet group (Figure 2.4). The 
influence of dietary Mn on the effect of endothelial cell to alter maximum response 
(Fmax, mean value ± SEM) to the adrenergic agonist (L-Phe) is presented in Figure 2.5. 
In endothelium-disrupted rings the maximum force of contraction (Fmax) was increased 
significantly following the increase in Mn concentration in the diet (Figure 2.4). The Phe-
induced constriction in the vascular smooth muscle (VSM) as described by the Fmax of 
disrupted rings was reduced MnD-fed animals and enhanced in MnS-fed animals when 
compared to the MnA/ Control group. 
In the presence of endothelium (endothelium-intact rings) the force developed in 
MnD-fed animals was not significantly different when compared to the Control group 
(Figure 2.4). However, aortic rings from animals supplemented with 45-50 ppm of Mn 
(MnS group) developed significantly lower Fmax when compared to both MnD and MnA 
animals (Figure 2.4). Supplementing the diet with 45-50 ppm of Mn did not change the 
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stores of Mn in the body.as described by hepatic and kidney Mn concentration (Table 
2.1) but it did reduce the contractile responses to the cci adrenergic agonist (Phe) in the rat 
aortic rings in comparison to the MnA (10-15 ppm). 
The effect of the presence of the endothelial cell is represented as the difference in 
Fmax between intact and disrupted rings. In MnD animals we observed a decreased effect 
or diminished role of the endothelium in the Phe-induced contraction of the aorta, when 
compared to the Control group (MnA). In MnS animals the effect of the endothelium on 
vasoconstriction was significantly enhanced. 
The mean maximum contraction force for each ring was used to calculate a 
percent increase of force in each dose, in order to determine the EC50 value (the effective 
concentration of L-Phe in which 50% of maximum contraction was obtained). The 
negative log (base 10) of the EC50 value was calculated to give us the pD2 value for each 
ring, a measure of vessel sensitivity to the a\ adrenergic receptor response. 
Vascular sensitivity (PD2) values for intact aortic ring contractions to L-Phe were 
significantly greater in MnD animals when compared to Controls (Figure 2.6). The 
vascular sensitivity of MnA and MnS animals did not appear to be significantly different. 
In the absence of endothelium, the vascular sensitivity to L-Phe appeared to be similar 
among diet groups. Thus, restriction of dietary Mn below the adequate levels (10-15 
ppm) appears to increase the vascular sensitivity to the ci| adrenergic receptor only in the 
presence of endothelium. 
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Figure 2.4. The effect of dietary Mn on maximum response (Fmax, mean value ± SEM) 
to the ai-adrenergic agonist (L-Phe) in endothelium-intact and endothelium-disrupted 
aortic rings in Sprague Dawley rat. 
2.5 
1.5 
0.5 
MnD MnA MnS 
Intact Rings 
MnD MnA MnS 
Disrupted Rings 
(*) Statistically significant differences at/?<0.001. 
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Figure 2.5. Influence of dietary Mn on the effect of endothelial cell to alter maximum 
response (Fmax, mean value ± SEM) to the adrenergic agonist (L-Phe) in Sprague 
Dawley rat. 
2 
1.9 
1.7 
1.6 
1.5 
1.4 
1.2 
MnD MnA MnS 
Differences between Disrupted-Intact Rings 
(*) Statistically significant differences at/?<0.001. 
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Figure 2.6. The effect of dietary Mn on vascular sensitivity O0D2, mean value ± SEM) to 
the (X)- adrenergic agonist (L-Phe) in endothelium-intact and endothelium-disrupted aortic 
rings in Sprague Dawley rat. 
5.5 
MnD MnA MnS 
Intact Rings 
MnD MnA MnS 
Disrupted Rings 
(*) Statistically significant differences at/?<0.001 compared to MnA/ Control group. 
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2.4. Discussion 
Manganese deficiency was confirmed by the suppression of animal growth in the 
MnD diet group, as well as by the lower hepatic Mn content (Table 2.1). Retardation of 
rodent growth in Mn deficiency has also been reported by previous studies [Kalea et al, 
2005]|.Taylor et al, I997]| Klimis-Tavantzis et al, 1993][Yang et al, 1998a][Yang et al, 
l998b]Paynter, 1980J|Fahim et al, L990][Malecki et al, 1994] and it seems to be an effect 
of reduced efficiency of food conversion with the dietary Mn depletion [Yang et al, 
1998a][Yang et al, 1998b]. The decrease in liver weight in MnD rats was proportional to 
the decrease in body weight in MnD animals as shown by the similar ratio of liver to 
body weight (Table 2.1). Kidney weight was similar among diet groups (Table 2.1). 
Manganese concentrations in liver and kidney were significantly reduced in the MnD diet 
group when compared to Control, while there were no differences among MnA and MnS 
animals (Table 2.1). 
We document for the first time that the presence of Mn in the diet affects the Phe-
induced contractions of the rat aortic vessel. The effect of the trace element included both 
the maximal contractile response to Phe and the membrane-related receptor sensitivity. 
Altering the Mn from control levels in the experimental diet, modified the above 
responses, which were affected by the presence of endothelium. 
In endothelium-disrupted aortic rings, dietary Mn enhanced vasoconstriction on 
an di adrenergic agonist (L-Phe) (maximum contraction: MnD < MnA/ Control < MnS). 
We observed an increased responsiveness of the vascular smooth muscle cells to the 
adrenergic agonist, which was independent from the receptor-agonist interaction (no 
differences in pD2 values) when compared to the MnA/ Control group. Additionally, 
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when Mn was supplemented in 45-50 ppm the vessel sensitivity (pD2) to the adrenergic 
agonist L-Phe was unaffected in both ring preparations (intact and disrupted); thus, 
supplementation of Mn in these levels does not affect the sensitivity of the adrenergic 
receptors in endothelial cell and vascular smooth muscle cell. 
In the presence of endothelium, we observed an increase in adrenergic receptor 
sensitivity (higher/7D2) with Mn deficiency when compared to Control diet group. This 
increase was not accompanied by any significant difference in the responsiveness of the 
contractile machinery (Fmax). Intact aortic rings from MnS (45-50ppm) animals 
demonstrated a marked decrease in responsiveness of the contractile machinery to L-Phe 
as demonstrated by a lower Fmax, which cannot be attributed to a decrease in vascular 
sensitivity to the adrenergic agonist (no significant differences in the/?D2 values between 
MnA and MnS groups). When the endothelial cell was disrupted, the responsiveness of 
the MnS rings to vasoconstriction was higher (increased Fmax), when compared to MnA 
but also to MnD rings. That is an indication that the hypocontractility of the MnS aortic 
rings and is attributed to the increased vasodilator tone of the endothelial cell layer, 
which balances the increased constriction of the vascular smooth muscle (as observed in 
disrupted rings). We conclude that Mn affects endothelial cells blunting the enhancement 
of Phe-induced vasoconstriction caused by the presence of Mn in VSM. The enhanced 
effect or role of Mn on the contractile efficiency of the VSM is not on the receptor level 
but rather on the contractile machinery. 
In rat aorta the contractile responses to selective ai adrenergic agonists are 
modulated by nitric oxide, which means that the absence of the endothelium will 
markedly potentiate the response to the agonist [Liischer & Vanhoutte, 1990]. In the case 
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of L-Phe which does not evoke a rise in cGMP, the effects of the endothelium removal is 
due to basal rather than stimulated release of endothelium-derived relaxing factor(s). 
In all our endothelium disrupted aortic rings we do observe a potentiation of the 
L-Phe-induced vasoconstriction in the presence of Mn. We know that the presence of a 
functional endothelium depresses the contractile actions of adrenoreceptor agonists 
| Allan et al, 19831|Carrier & White, 1985][Adeagbo & Triggle, 1993] an action 
attributed to the spontaneous release of endothelium-derived relaxing factor(s) and 
physiological antagonism of the contractile process. Endothelial disruption eliminates the 
role of endothelium in vascular contraction and thus augments vascular contractions to a 
variety of agonists [Martin et al, 1988]. Thus, in disrupted aortic rings we observe an 
enhanced response to vasoconstrictors, such as Phe, and a reduced relaxation to 
vasodilators such as Ach. These modified responses have been studied in different 
techniques of mechanical removal of the endothelial layer (Molina, 1992). The effect of 
the endothelium seems to be more pronounced in the MnS animals when compared to 
MnA and less pronounced in MnD animals when compared to the MnA/ Control animals 
(Figure 2.4). 
In our study we examined vascular responsiveness to adrenergic stimulation of 
animals fed diets with different concentrations of Mn. We examined the ai adrenergic 
receptor mediated vasoconstriction using L-Phe, a synthetic catecholamine that causes 
VSM contraction. Phenylephrine binds to and activates the G-protein type ai adrenergic 
receptor, which leads to the hydrolysis of phosphoinositol biphosphate (PIP2) to inositol 
triphosphate (IP3) and diacylglycerol (DAG). Inositol triphosphate stimulates the release 
of calcium from intracellular stores, which acts as a second messenger and initiates a 
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cascade of events that lead to vascular smooth muscle contraction. Dietary Mn is a 
multifunctional trace element that may interfere in several different ways in that cascade 
of events and thus may be responsible for modulating vascular tone. 
Studies in vitro have shown that when Mn is present in small concentrations (0.3-
3(imol/L), it inhibits the vascular contractions induced by noradrenaline, 5-
hydroxytryptamine and potassium in porcine coronary artery, goat and human cerebral 
arteries and in rat aorta [Yan et al, 1998J[Yan et al, 2001]. In our study, we observed the 
effect of dietary intake of Mn on the Phe-induced contractions in the Sprague-Dawley rat 
aorta and confirmed the suppressor effect of Mn on ai adrenergic agonist induced-
vasoconstriction of intact rings ex vivo. Our results showed that dietary Mn shifted the 
Phe dose-response curves to the right with a significant reduction in the maximum 
contractile response at Mn levels higher than 10-15 ppm. The exact mechanism involved 
in such inhibitory action of Mn is still unknown. Interestingly, this shift occurred when 
dietary Mn was supplemented (45-50 ppm) even though we observed no difference in the 
hepatic or kidney Mn concentration between the MnA and MnS groups (Table 2.1) 
suggesting that the contractile mechanism is more sensitive than the storage index for 
Mn. 
Previous in vitro observations support several hypotheses that might explain the 
role of Mn in suppressing agonist-induced vasoconstriction [Liu et al, 2002][Yan et al, 
1998][Yan et al, 200l][Salaices et al, 1983][Kuribayashi, 1969][Sullivan et al, 1968], 
One of these hypotheses is that Mn can pass through voltage-dependent Ca+2 channels 
and might share a Ca -blocking property in smooth muscle cells by antagonizing Ca 
[Yanetal, !998][Yan et al, 200J][Kuribayashi, 1969][Clarkson, 1993][Deth et al, 1981]. 
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A complete depletion of the intracellular Ca+~ pool is known to activate Mn non-
permeable Ca+2 influx from the extracellular space in portal vein smooth muscle cells, in 
the presence of an adrenergic receptor agonist (in our case L-Phe) [Pacaud et al, 
1993||Kwan et al, 2003]. This observation may explain the reduction in responsiveness 
of the contractile machinery of the rat aorta in the presence of dietary Mn >45 ppm as 
well as our finding that the hypocontractility of intact MnS rings is independent from the 
vascular sensitivity of the aorta to the adrenergic agonist. This hypothesis would not 
explain the enhanced vasoconstriction of VSM in the presence of Mn. Such an 
enhancement in maximum force developed indicates that the presence of Mn enhances 
the efficiency of the contractile machinery in the VSM and could imply an effect of the 
trace element on the cross bridge formation. 
Manganese is known to affect the synthesis of metalloenzymes that protect the 
cell membrane structure from oxidative stress, such as Mn superoxide dismutase 
[Malecki et al, 1994][Zanetti et al, 2001][Wambi-Kiesse et al, 1999]. The presence of 
free radicals (O2" generation) represents an important mechanism for endothelial 
dysfunction by reducing the bioavailability of the endothelium-derived relaxing factor 
nitric oxide (NO) [Gao et al, 19941 [Williams et al, 1998][Matsuoka, 2001]. Ensunsaetal. 
[Ensunsa et al, 2002] have reported lower levels of liver endothelial nitric oxide synthase 
(NOS III) in Mn deficient animals and increased production of peroxinitrite products, 
which in turn may have an effect on the bioavailability of nitric oxide in the endothelial 
cell layer [Harris et al, 1995]. Decreased bioavailability of endothelial-released nitric 
oxide is associated with decreased vasorelaxation and may affect the biomechanical 
properties of the contractile machinery. 
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In our study we did not observe any differences in vasoconstriction of MnD rings 
when compared to Control rings, even though there was an increased vascular sensitivity 
to the adrenergic agonist (higher pD2 of intact MnD rings but not of disrupted). However, 
we did observe a decreased constriction of the VSM in MnD rings only, when compared 
to the Control group, which was independent of the vascular smooth muscle cell 
sensitivity. This may suggest an impaired ability of the endothelial cell in MnD animals 
to synthesize vasodilators or protect their integrity in order to counterbalance 
vasoconstriction, which may be explained by the increased oxidative stress and decreased 
NO bioavailability in case of Mn deficiency. 
In addition to a role for Mn in the contractile machinery of the vascular smooth 
muscle, our results show an increase in /7D2 values in the MnD group in intact rings only 
(Figure 2.5). These results occurred without a change in Fmax (Figure 2.5), we suggest 
that there is an increase in a.\ adrenergic receptor sensitivity of the endothelial layer 
during dietary Mn deficiency. Since Mn participates in the structure of the extracellular 
cell matrix (ECM) by affecting the synthesis and structure of certain glycosaminoglycan 
molecules (chondroitin sulfate and heparan sulfate) [Kalea et al, 2005J[Yang et al, 
1998][Yang et al, 1998b] and affects their sulfation pattern, it might also modulate 
agonist actions or interfere in the agonist-receptor binding or affect the receptor structure 
itself [Edwards et al, 1988][Strott, 2002][Lyon et al, 1998]. It has been reported that 
glycosaminoglycan molecules act as cellular co-receptors in order to facilitate the binding 
of receptors with ligands such as growth factors (VEGF, FGF etc) and lipoproteins 
[Kramer et al, 2003J. These cell surface receptor-ligand complexes are involved in the 
process of cellular signal transfer by affecting the responsiveness of the cellular 
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membrane to extracellular ligands, especially at low ligand concentrations [Risler et al. 
20021. Previous transmission microscopy studies conducted in our laboratory, reported a 
decreased density of the endothelium cell layer in Mn deficiency that may affect either 
the adrenergic receptor number or affinity [Ekanayake & Klimis, 1995]. However we did 
not measure directly the receptor number, affinity or occupancy. 
Despite the expanding plethora of studies on the role of nutrients on the 
biomechanical properties of the vasculature, there are still many gaps on defining the 
exact signaling pathways and second messengers that are implicated to regulate 
contraction and relaxation within the cell. It has been reported that approximately only one 
Lhird of all cardiovascular events can be extrapolated on the basis of "accepted" risk factors. 
Additional determinants may exist and trace minerals may be potential candidates. 
Manganese is a multifunctional trace element participating in many fundamental 
processes in the cell [Korc, 1993]. Its effect on the vascular system, such as the control of 
vasomotor tone and blood pressure regulation still remains to be unraveled. Our results 
demonstrate, for the first time, that dietary Mn is implicated in the vascular contractile 
model, affecting the mechanical properties of blood vessels and regulating vascular tone. 
This effect depends on its concentration in the diet and on the presence of a viable 
endothelium. 
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Chapter 3 
The Effect of Dietary Manganese on Endothelium-Dependent 
and Endothelium-Independent Vasodilation 
In the present study we examined the effect of dietary manganese (Mn) on the 
vasodilation of rat aorta. Weanling male Sprague-Dawley rats were fed either a Mn 
deficient (MnD), adequate (MnAJ Control) or supplemented (MnS) diet (<1, 10-15 and 
45-50 ppm Mn respectively). Following 14 weeks on the diet the rats were sacrificed and 
3 mm aortic rings were prepared. After equilibration and preconditioning, aortic rings 
were precontracted with one dose of the oi| adrenergic receptor agonist L-Phenylephrine 
(L-Phe, 10 M). Cumulative applications of seven concentrations of Acetylcholine (Ach, 
3 x 10"9, 10"8, 3x 10"8, 10"7, 3x 10"7, 10"6, 3x 10"6M) were applied to induce endothelium-
dependent vasodilation. A second concentration response curve was applied after the 
same precontraction, using eight doses of sodium nitroprusside (SNP, 3x 10" , 10" , 3x 10" 
8
, 10 7, 3x 10"7, 10"6, 3x 10"6, 10"5M) to assess endothelium-independent vasodilation. The 
percentage of relaxation to the initial precontraction was used to determine the vessel 
sensitivity (pD ) to Ach and SNP. 
Manganese deficiency, assessed by hepatic Mn content, significantly lowered the 
rate of animal growth. A two-way Analysis of Variance (ANOVA) test revealed that Ach 
produced decreased vasodilation in aortas of MnD and MnS rats, in comparison to MnA. 
The vessel sensitivity (lower pD2) of the MnS aortas to Ach was reduced compared to the 
MnA/ Control group, while MnD and MnA animals appeared to have similar vessel 
sensitivity to the agonist (Ach). The absence of dietary Mn appeared to reduce the 
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vasodilatory effect of the endothelium, possibly by affecting nitric oxide production or 
bioavailability. The above alterations in Ach-induced vasodilation could not be attributed 
to membrane-related effects. The presence of Mn in levels of supplementation (45-50 
ppm) reduced Ach-induced vasodilation and vessel sensitivity to the agonist, acting as a 
non-competitive antagonist on the vasodilatory effect. The effect of the different dietary 
Mn concentrations on SNP-induced vasodilation was similar but much smaller when 
compared to Ach-induced vasodilation. Dietary Mn seems to affect vasodilation by acting 
primarily on the NO pathway and to a lesser extent on the cGMP pathway of the vascular 
smooth muscle. Our results confirm the effect of Mn on endothelium-dependent 
vasodilation in rat aorta and its multifunctional role on the regulation of vasomotor tone. 
3.1. Introduction 
The endothelium consists a physical barrier of the aortic tissue between 
circulating blood components and the perivascular tissues. One of the major roles of the 
endothelial layer is the regulation of vascular tone by releasing relaxing factors that serve 
as second messengers and regulate the biomechanical properties of the vessel [Fleisch, 
1974J. These second messengers can be divided in two classes: the endothelium-derived 
relaxing factors (EDRFs) and the endothelium-derived contracting factors (EDCFs) 
[Luscher & Vanhoutte, 1990][Moncada et al, 1993][Moncada et al, 1991]. Nitric oxide 
(NO), prostacyclin (a product of the cyclooxygenase pathway) and endothelium-derived 
hyperpolarizing factor (EDHF) are among the major relaxing factors and cause dilation of 
the vascular smooth muscle. Endothelin-1, thromboxane and prostaglandin H2 are among 
the major endothelium-derived contracting factors (EDCFs) [Luscher & Vanhoutte, 
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1990]. Shear stress as well as cell membrane receptors activated by hormones and 
autacoids stimulate the release of nitric oxide (NO) from endothelium by the formation of 
L-citrulline from L-arginine [Russo et al, 2002]. NO diffuses to the vascular smooth 
muscle (VSM) and induces vasodilation through the activation of soluble guanylate 
cyclase (sGC) and the formation of cGMP |Lucas et al, 2000]. Prostacyclin, a product of 
cyclooxygenase, leads to the formation of cAMP by activating adenylate cyclase and acts 
synergistically with NO inducing vasodilation [Luscher & Vanhoutte, 1990][Salvemini, 
1996J. Finally, EDHF induces vasodilation by hyperpolarizing the VSM cell membrane 
with the opening of K+ ion channels [Feletou et al, 2000]. 
Endothelial dysfunction and vascular dysregulation are observed in many 
cardiovascular diseases such as atherosclerosis, hypertension, heart failure, coronary 
heart disease and stroke [Cai et al, 2000][De Vriese, 2000][Loscalzo, 2000][Boulanger, 
l999][Shimokawa, 1999][Mombouli et al, 1999]. The dysfunction of the endothelial 
layer leads to impaired bioavailability of NO and thus NO deficiency, which has been 
implicated in a variety of pathological conditions [Russo et al, 2002]. Limited NO 
bioavailability might be a result of decreased synthesis, impaired bioavailability of the 
bioactive NO or enhanced NO inactivation and production of its metabolites [Matsuoka, 
2001]. As a result, the signal transduction processes in which NO is implicated as a 
second messenger are obstructed as well as the normal or protective physiological 
processes that they regulate. 
One of the major functions of Mn lies in its role as an enzyme cofactor (Mn-
activated enzymes) or as a structural part of enzyme molecules (Mn-containing enzymes) 
[Wedler, 1994]. Arginase, manganese superoxide dismutase (MnSOD) and guanylate 
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cyclase (GC) are some of the major representatives of the Mn-metalloenzymes with 
important roles in vascular cell pathways. Arginase catalyzes the formation of L-ornithine 
from L-arginine, which is the substrate for NO formation [Mori et al, 2000]. Manganese 
superoxide dismutase of mitochondrial origin provides one of the major antioxidant 
mechanisms by causing dismutation of superoxide (Ov) leading to the formation of the 
less active form of hydrogen peroxide (H2O2) [Zanetti et al, 2001]. Thus, MnSOD 
prevents the interaction of superoxide with NO which leads to inactivation of NO and 
formation of its by-products (peroxynitrite ONOO-, nitrite NO2 and nitrate (and NO3). 
Inactivation of the EDNO will affect cell-signaling pathways of vasodilation. 
In our previous studies we reported reduced contractility of rat intact aortic rings 
when challenged with an adrenergic agonist, observed when Mn was present at levels of 
supplementation (45-50ppm). However, the presence of dietary Mn in the absence of 
endothelium, appeared to increase vascular smooth muscle (VSM) contraction. Aortas of 
MnD animals presented increased vessel sensitivity (pD2) to the adrenergic agonist in 
endothelium-intact aortic rings. This finding along with the increase in vascular force of 
contraction in MnS aortas in the VSM suggest that the effect of Mn on the regulation of 
vasomotor lone takes place through an endothelium-mediated pathway, possibly by 
affecting the vasodilator tone [Kalea et al, 2002][Kalea et al, 2003][Kalea et al, 2005]. 
There have been few in vitro [Kasten et al, 1994] and in vivo studies [Ensunsa et al, 
2004], which have suggested different effects of Mn on endothelium-mediated 
vasodilation. The goal of this study was to investigate the effect of dietary Mn on 
Acetylcholine (Ach)-induced vasodilation (endothelium-dependent) and on Sodium 
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Nitroprusside (SNP)-induced vasodilation (endothelium-independent) in male Sprague-
Dawley rats fed three different concentrations of Mn. 
3. 2. Materials and Methods 
3.2.1. Animal Model 
Fourty eight weanling male Sprague-Dawley rats (Charles River Laboratories, 
Wilmington, MA) were randomly assigned to three groups of sixteen rats, each on a Mn 
deficient (MnD), Mn adequate (MnA) and Mn supplemented (MnS) diet with <lppm, 10-
15ppm and 45-50 ppm of Mn respectively. The above Mn levels were chosen because 
studies indicate that a Mn level of less than 1.0 ppm results in Mn deficiency in about 
thirteen to fifteen weeks [Taylor et al, l997][Klimis-Tavantzis et at, 1993][Yang et al, 
1998][Yang et al, 1998b][Kalea et al, 2005] and ten ppm dietary Mn levels have been 
reported by the American Institute of Nutrition (AIN) as an adequate level to prevent 
deficiency in the rat [Reeves et al, 1993]. The animals were individually housed in metal 
mesh-bottomed cages in an environmentally controlled room (22°C with a 12:12 hrs 
light:dark cycle). All animals were weighed weekly. The Animal Care and Use Committee 
of the University of Maine approved all animal care and experimental procedures. 
3.2.2. Diets 
Diets were mixed in our laboratory from purified ingredients [Yang et al, 
1998a][Yang et al, 1998b][Kalea et al, 2005], they were prepared fresh and they were 
refrigerated at 4°C for maximum of three days after preparation. Diets contained dextrose 
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69.1%, egg white solids 20%, corn oil 6%, vitamin mix 1%, mineral mix 1.5%, biotin 0.2 
%o and D-L-Methionine 0.4%. Vitamin (A.O.A.C. Special Vitamin Mixture, Harlan 
Tekland) and mineral mixes (MMP Biochemicals) were commercially prepared. 
Manganese content of the diets and tap water were determined by atomic absorption 
spectroscopy at the Maine Forest and Agriculture Experiment Station Analytical 
Laboratory, Plant and Soil Department of the University of Maine (detection limit 0.01 
ppm). Diet content of Mn was tested every time following preparation. Tap water (below 
the detection limit for Mn) and food were provided ad libitum. 
3.2.3. Tissue Sampling 
At the end of the feeding period, rat food was withheld for 12-14 hrs. The animals 
were anesthetized in a chamber with 95% CO2 / 5% O2, for approximately 2 min. 
Thoracic aortas and livers were removed carefully and washed with physiologic salt 
solution (PSS, with composition in mmol/L: NaCl, 118, KC1, 4.7, NaHC03, 25, KH2P04, 
1.18, MgSO/i, 1.17, Dextrose, 11, CaCL:, 1.25). Liver tissues were weighted, lyophilized, 
pulverized and analyzed for Mn content using an atomic absorption spectrophotometer 
with a graphite furnace atomizer at the Maine Forest and Agriculture Experiment Station 
Analytical Laboratory, Plant and Soil Department of the University of Maine. 
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3.2.4. Vascular Ring Studies 
3.2.4.1. Aortic Preparations 
The thoracic aorta was excised and submerged in a petri dish filled with 
physiologic salt solution (PSS) at room temperature. The aortic segment was cleaned of 
adherent extravascular tissue and divided into four rings of 3 mm length, which were 
selected from the middle section of the vessel. One ring from each animal was used for 
the following protocols. Two stainless steel wire triangles (0.012 in diameter) were 
passed carefully through each ring, which was mounted in a 20 ml Radnotti tissue bath 
containing PSS (37°C, continuously bubbled with a 95% 0 2 and 5% CO2 mixture to keep 
the pH at 7.4). The aortic ring was attached through the one triangle to a fixed glass hook 
in the tissue bath and through the other triangle and a weightless wire hook to a force 
transducer for the measurement of isometric force. The transducer was connected to a 
tissue force analyzer (Model 410, MicroMed, Louisville, KY), which was continuously 
displayed and recorded on-line on a computer. 
Each ring was stretched to produce a resting tension (preload) of 1.5g from the 
initiation of the experiment |Beach et al, 2001 |[Adeagbo et al, 1993J[Kawabe et al, 
2003]. Tissues were allowed to equilibrate for 45min. During this time, all rings were 
washed with PSS (37°C, pH 7.4) and were precontracted for lOmin with one maximal 
dose of L-Phe (10"" M) and one dose of Ach (10 8 M) to saturate the non-selective 
receptor binding sites for the agonists. After washing the tissues four times, the preload 
was corrected to the original baseline levels and remained unchanged throughout the 
experiment. 
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3.2.4.2. Endothelium-Dependent Vasodilation 
Following preconditioning the aortic rings were precontracted with one maxima) 
dose of the a( adrenergic agonist L-Phenylephrine (10"6M) for lOmin, which was the 
duration necessary for the contraction curve to reach a plateau. Following the L-Phe 
precontraction, cumulative applications of seven concentrations of Ach (3 x 10" , 10" , 3x 
10"8, 10"7, 3x 10"7, 10"6, 3x 10"6M) were applied, similarly to previous protocols 
[Schuschke et al, 1992][Beach et al, 2001]. A drug-tissue contact time of six min was 
allowed for each Ach concentration to achieve the maximum dilation to the initial 
precontraction. 
3.2.4.3. Endothelium-Independent Vasodilation 
Following the above protocol (3.2.4.2), the aortic rings were washed four times 
over a 20min period with aerated PSS (37°C, pH 7.4) and were allowed to equilibrate to 
baseline to bring aortic tension slightly below or down to the initial preload level. 
Endothelium independent dilation was then assessed with seven doses of SNP (3xl0"9, 
I0"8, 3x 10"8, 10"7, 3x 10"7, 10"6, 3x 10"6M) as previously described [Kawabe et al, 2003]. 
Sodium nitroprusside is a nitric oxide donor and a cGMP-dependent vasodilator. A drug-
tissue contact time of four min was allowed for each SNP concentration to achieve the 
maximum dilation for each dose. One dose of the non-selective and endothelium-
independent vasodilator papaverine (10"3 M) was used in the end to obtain maximal 
vasodilation. Papaverine is a non-specific inhibitor of phosphodiesterase in the smooth 
muscle; it increases cAMP and cGMP concentrations, inducing indirectly vasodilation. 
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3.2.5. Drugs 
Acetylcholine chloride, Sodium Nitroprusside, Papaverine, L-Phenylephrine and 
salts for the stock solutions of the physiologic salt solution (PSS: NaCl, KG, NaHCCb, 
KH2P04, MgS04, Dextrose, CaCl2) were purchased in pure forms from Sigma-Aldrich 
Chemical Co (St Louis, MO, U.S.A.) and were dissolved in distilled water. 
3.2.6. Statistical Analysis 
Animal weights and hepatic Mn content were compared using a one-way analysis 
of variance (ANOVA). The relaxant effect to each Ach dose was expressed as a 
percentage dilation to the initial L-Phe precontraction. Concentration response curves 
were fitted by nonlinear regression with simple algorithm and EC50 and pD2 (pD2=-
logioEC5o) were calculated. The pD2 values for the rings of all animals show differences 
in the vessel sensitivity to the Ach receptor. All results were expressed as mean values ± 
standard error of the mean (SEM). The percentages of dilation and pD2 values to Ach 
were compared in different two-way analysis of variance (ANOVA) tests in order to 
determine the effect of different diets on vasodilation and on vessel sensitivity. Student 
Newman-Keuls tests were used for statistical analysis and a p-value level of 0.05 or less 
was considered as statistically significant. The Sigmastat Statistical Program Package 
(SAS Institute, Cary, NC) was used to conduct the statistical analysis. 
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3.3. Results 
3.3. J. Animal Growth 
All animals fed a MnD, MnA or MnS diet gained weight. However, mean body 
weights were significantly different among all groups (Table 3.1). The difference in 
growth rate was statistically significant from the fourth week on as has been described 
before [Kalea et al, 2005][Yang et al, 1998a], The differences in liver weights among diet 
groups (Table 3.1) were proportionate to the differences in body weight as appears in the 
similar percentages of liver weight to body weight of the rats (Table 3.1), an indicator of 
normal growth. Manganese deficiency was confirmed by hepatic Mn content, which was 
decreased only in the MnD group (Figure 3.1). 
Table 3.1. Effects of dietary Mn on body weight, liver weight and hepatic Mn content. 
Diet Body Liver Liver weight/ Hepatic Mn content 
Groups weight (g) weight (g) Body weight (ppm) 
MnD 462 ± 13 * 13.57 ± 0.58* 2.9 ±0.001 1.223 ±0.05* 
MnA 526 ± 22 16.09 ±0.93 3.0 ±0.001 5.483 ±0.186 
MnS 539 ± 6 * 16.69 ±0.64* 3.09 ±0.001 5.652 ±0.243 
(*) Statistically significant differences atp<0.05 compared to MnA/ Control group. 
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3.3.2. Endothelium-Dependent Vasodilation 
Seven cumulative doses were used to give Ach concentrations of 3 x 10' to 3 x 
10"6 M in three fold steps in the tissue baths. Each dose produced a graded decrease of the 
precontraction force that was obtained with one dose of L-Phe. A maximum contraction 
force was developed in response to the initial precontraction dose of L-Phe and was 
considered to be the point of 0% dilation (percentage of the level of precontraction), in 
order to set a baseline of initial precontraction similar for all rings. In the end of the 
cumulative Ach dilation curve the force returned to a lower level than its initial passive 
tension (preload). The baseline point (preload, Og of force developed) was considered to 
be the 100% dilation. Washout of agonists four times after the end of the protocol 
allowed the force to return at least to the preload value. All rings relaxed more than 100% 
in the completion of the Ach dose response curve. Acetylcholine-induced vasodilation 
was lower in both MnD and MnS diet groups when compared to MnA (Appendix, Figure 
A.l). Maximum % of vasodilation was significantly reduced in MnD and MnS groups 
when compared to MnA (Figure 3.1). 
In order to determine the EC50 value, the mean maximum dilation force for each 
ring was used to calculate a percent decrease of force in each dose (the effective 
concentration of Ach in which 50 % of maximum dilation was obtained). The negative 
log (base 10) of the EC5o value was calculated to give us the pD2 value for each ring, a 
measure of vessel sensitivity to the Ach receptor response. 
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Figure 3.1. Effects of dietary Mn on endothelium-dependent vasodilation (% of 
precontraction) of intact aortic rings in Sprague Dawley rat. 
1.6 
MnD MnA 
Diet Groups 
(*) Statistically significant differences at/?<0.001. 
MnS 
Figure 3.2. Effects of dietary Mn on vascular sensitivity to Ach (pD2, mean value ± 
SEM) of aortic rings in Sprague Dawley rat. 
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i
*
)
 Statistically significant differences at/?<0.001. 
MnS 
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The pD2 values for aortic ring dilations to Ach were compared among diet groups 
(Figure 3.2). Animals fed a MnD (<1 ppm) or a MnA (10-15 ppm) diet presented similar 
pD2 values for Ach-induced relaxation of the L-Phe precontracted aortic rings. However, 
in animals fed a MnS diet (45-50 ppm) we observed a significantly reduced pD2 value for 
Ach-induced relaxation when compared to MnA-fed animals (Figure 3.2). The relaxation 
to the one dose of papaverine was similar among diet groups. 
3.3.3. Endothelium-Independent Vasodilation 
Similarly, eight cumulative doses of SNP were used to give concentrations of 3 x 
10"9 to 10"5 M in three fold steps in the tissue baths in order to decrease the precontraction 
force that was developed with the same dose of L-Phe. The decrease of force to the 
preload level (100% of dilation) was used to calculate a percent decrease in tension for 
each dose in each respective concentration-response curve to SNP. EC50 values were 
determined for each ring (the effective concentration of SNP in which 50% of maximum 
dilation was obtained). The negative log (base 10) of the EC50 value was calculated to 
give us the pD2 value for each ring, a measure of vessel sensitivity to the SNP-induced 
dilation. The pD2 values for aortic ring dilations to SNP were compared among diet 
groups. 
Even though we observed a reduced vasodilation to SNP in MnD and MnS 
groups, in comparison to MnA (Figure 3.3. and Appendix Figure A.2.), there were no 
statistically significant differences in vessel sensitivity to SNP among diet groups (Figure 
3.4). 
61 
Figure 3.3. Effects of dietary Mn on endothelium-independent vasodilation (Fmax, mean 
value ± SEM) of aortic rings in Sprague Dawley rat. 
1.2 
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(*) Statistically significant differences at/?<0.001. 
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Figure 3.4. Effects of dietary Mn on vascular sensitivity to SNP (pD2, mean value 
SEM) of aortic rings in Sprague Dawley rat. 
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3.4. Discussion 
In the present study we document that the presence of Mn in the diet affects 
primarily the function of the endothelial layer since we observed significant differences 
among diet groups in endothelium-dependent vasodilation (induced by Ach) and in a 
much smaller extend in endothelium-independent vasodilation as induced by a direct 
smooth muscle relaxant (induced by SNP) (Appendix, Figures A.l. and A.2). In MnS diet 
group we observed a pronounced decrease of the Ach receptor sensitivity Q9D2) compared 
to the MnA group (Figure 3.2). The vessel sensitivity (pD2) to endothelium-independent 
vasodilation was not affected by the absence of Mn from the diet (<lppm) neither its 
supplementation at levels of 45-50 ppm (Figure 3.4). 
In Ach-induced vasodilation absence of Mn from the diet did not appear to affect 
the vessel sensitivity to the agonist (Ach), while it reduced the maximum dilation when 
compared to MnA group (Figures 3.1 and 3.2). Such an effect might be attributed to a 
reduction of the vasodilatory effect of the endothelial cell. Thus, inadequate Mn intake 
seems to reduce the production, release or bioactivity of endothelium-generated 
vasodilators, without affecting membrane-related events. We know that Mn is a cofactor 
for MnSOD, one of the major antioxidant defense systems of endothelial cells that 
scavenge the deleterious free radical superoxide. In severe Mn deficiency, the activity of 
MnSOD is reduced allowing the formation of superoxide [Malecki et al, 1994][Malecki et 
al, 19961, which reacts with and inactivates NO. An increase in formation of NO by-
products is an indication of NO inactivation. Even though we have information on the 
reduced activity of heart, liver and kidney MnSOD in Mn deficiency, there is no 
information on the effect of Mn deficiency on MnSOD of the vascular tissue [Ensunsa et 
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al, 2()()4][Malecki et a], 1994][Malecki et al, 1996]. Similarly, reports on the increased 
formation of NO by-products are limited and concern only enzyme activity in liver tissue 
[Ensunsaetal, 20031. 
When Mn is present in levels of supplementation (MnS) the vessel sensitivity to 
Ach is decreased, suggesting that dietary intake of Mn at 45-50 ppm might affect the 
receptor-agonist interaction. Activation of the Ach receptor in the vascular endothelium 
results in an influx of Ca+2 and stimulation of NOS III, which leads to the production of 
NO from L-arginine. Nitric oxide diffuses to nearby smooth muscle cells and reacts with 
the ferrous iron in the heme prosthetic group of the sGS. Activation of sGC catalyzes the 
formation of cGMP from GTP, which leads to dephosphorylation of myosin light chains 
in the contractile machinery and to vasodilation [Moncada et al, 1993j. Elevated 
production of NO through the activity of NOS seems to be responsible for vascular 
hypocontractility. Additionally, Ach leads to the production of endothelium-derived 
vasodilators such as eicosanoids, which contribute to endothelium-dependent 
vasodilation [Vanhoutte, 19901. Hyperpolarization of the VSM cell membrane by Ach 
contributes the diffusible EDHF, which induces vasodilation and is different from NO 
and prostacyclin [Vanhoutte, 2003J. Potassium ions, hydrogen peroxide and 
epoxyeicosatrienoic acid are among the most recent speculations on the nature of EDHF, 
which still remains unknown [Feletou et al, 2000]. In MnS diet, a decrease in Ach-
induced vasorelaxation could be due to an enhanced Phe-induced precontraction of the 
VSM, which has been reported previously [Kalea et al, 2003]. It might also suggest a 
decrease in synthesis/ release of NO from endothelial cells due to increased degradation 
of NO or an effect of dietary Mn on the Ach receptor. 
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It has been well documented in the past that dietary Mn affects the concentration 
and synthesis of proteoglycan and glycosaminoglycan (GAG) structures in rat aorta 
[Yang et al, 1998][Yang et al, 1998b][Klimis-Tavantzis et al, 1989]. We have also 
recently reported alterations in the disaccharide composition and sulfation pattern of 
heparan sulfate glycosaminoglycans [Kalea et al, 2005]. The highly diverse structure of 
GAG molecules enables them to interact in divergent ways with biologically effective 
molecules, such as receptors, enzymes, cytokines, growth factors and proteins [Wight et 
al, 1992], Oversulfated disaccharide domains facilitate the binding of HSPGs with 
growth factors, matrix components, effectors and modulators of enzymatic catalysis 
[Militsopoulou et al, 2003], since sulfonation is the recognized primary mechanism that 
influences biological activity by determining high specificity in these receptor-ligand 
binding interactions [Strott, 2002][Lyon et al, 1998]. 
Even though the physiological role of HSPGs as co-receptors is still not clear in 
many cases, it seems that overexpression of HSPGs increases vascular sensitivity to 
agonists, an indicator of the binding affinity of the ligand with the specific receptor, 
especially in low ligand concentrations [Risler et al, 2002][Kramer KL et al, 2003]. It 
has also been reported that oversulfated HS proteoglycans upregulate the gene expression 
and clustering (aggregation) of Ach receptors in vitro [Meier et al, 1998][Jones et al, 
19961[McDonnel et al, 2004]. In our recent studies, aortas from MnS-fed rats (45-50 
ppm) presented a significantly higher concentration of non-sulfated disaccharides, while 
MnD and MnA appeared to have increased concentration of oversulfated (tri- and di-) HS 
disaccharides. A reduced sulfation in the HS proteoglycans on the MnS rats might affect 
the expression or activation of Ach receptors in this diet group, in which we could 
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attribute the decreased vessel sensitivity to Ach in MnS animals, provided that we do 
have maximum receptor occupancy in our experimental conditions. However, in our 
study we did not measure directly the receptor number, affinity or occupancy in our 
experiments, which would be necessary to support such hypothesis. 
Ensunsa et al. [Ensunsa et al, 2004] recently reported a decreased vascular 
sensitivity to Ach in aortic rings from rats fed a MnS diet, while they did not observe any 
statistically significant differences to SNP-induced vasodilation. In their experimental 
protocol they have used MnD female offsprings of MnD Sprague Dawley rats and 
compared Lhem with MnS-fed rats (45 ppm) without using a MnA/ Control diet group. 
Our results are in accordance with the findings of this study (reduced Fmax and pD2 in 
MnS group when compared to MnD). The same study [Ensunsa et al, 2004] supported 
that the increased vasodilation observed in the MnD diet group (compared to MnS) may 
be attributed to the increased availability of NOS and NO production due to the 
attenuated activity of arginase (which competes with eNOS for the substrate L-arginine) 
in the MnD diet group. However, this and previous studies reported a reduced liver and 
kidney but not vascular arginase activity in MnD diets. Arginase levels have always been 
compared to diets with Mn concentration much higher than 10-15 ppm (45, 48 and 
50ppm) [Brock et al, l994][Kirchgessner et al, 1978J[Sabbatini et al, 2003][Ensunsa et 
al, 2004]. Thus, we can not support that arginase deficiency in vascular tissue might 
affect the endothelium-dependent vasodilation in our experiments. 
The reduced Ach-induced vasodilation in MnD and MnS diet groups might reflect 
a change in the sensitivity of the vascular smooth muscle to relaxation by NO. Such an 
effect though would alter the responses to the NO-donor SNP, which is not supported 
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from our observations on the endothelium-independent vasodilation. Sodium 
nitroprusside is a NO-donor, which acts on cGMP to induce vasorelaxation. Even though 
Mn is a cofactor for sGC which catalyzes the formation of cGMP, the effect of Mn on 
VSM vasodilation seems to be of limited biological significance in comparison to its 
effect on endothelium-mediated vasodilation. Additionally, vessel sensitivity to the NO 
donor (pD2 for SNP) was similar among diet groups. Our data suggest that dietary Mn 
does not have a pronounced effect on vasodilation at post-receptor level. 
Our results suggest that the presence of Mn in the diet in concentrations lower or 
higher than 10-15ppm (adequate levels) reduces endothelium-dependent vasodilation by 
different mechanisms. In Mn deficiency the vasodilatory effect of the endothelium is 
reduced, possibly due to a compromised antioxidant defense system which reduces NO 
bioavailability. In levels of supplementation (45-50 ppm) the effect of Mn might be 
attributed to an enhanced VSM contraction or an effect on the Ach receptor expression or 
activation. The mechanisms responsible for the alterations on the endothelium-dependent 
vasodilation observed in the MnS diet group may include possible alterations in the 
L-arginine/NO pathway (generation of NO) or in the cyclooxygenase-dependent EDCF 
production which interacts with the NO pathway and need to be further dissected. 
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Chapter 4 
The Effect of Dietary Manganese on Nitric Oxide Synthesis in Rat Aorta 
Previously we reported that dietary manganese (Mn) affects the endothelium-
dependent vasodilation pathways in rat aorta and has a smaller effect on cGMP pathway 
in the vascular smooth muscle (VSM). In the present study we examined the mechanism 
by which dietary Mn might affect two different endothelium-dependent vasodilation 
pathways, the L-arginine/nitric oxide (NO) and the cyclooxygenase (COX) pathway. 
Weanling male Sprague-Dawley rats were fed either a Mn deficient (MnD), adequate 
(MnA/ Control) or supplemented (MnS) diet (<1, 10-15 and 45-50 ppm Mn respectively). 
Following 14 weeks on the diet rats were sacrificed and four 3 mm aortic rings were 
prepared. One ring from each animal was incubated with physiological salt solution 
(PSS) only. Two of the three aortic rings from each animal were suspended in PSS with 
inhibitors: one ring with the inhibitor of nitric oxide synthase (NOS) L-/v -monomethyl-
arginme (L-NMMA, 10"4M) and one ring with the COX inhibitor mefenamic acid (MFA, 
10" M). The third ring was incubated in PSS with L-arginine (10" M), the substrate for 
NO formation. All rings were equilibrated and preconditioned for 45 min and they were 
precontracted with one dose of the at adrenergic receptor agonist L-Phenylephrine (L-
-6 
Phe, 10 M) to induce maximum contraction. Cumulative applications of seven 
concentrations of Acetylcholine (Ach, 3 x 10"9, 10~8, 3 x 10"8, 10~7, 3 x 10"7, 10"6, 3 x 10"6 
M) were applied to induce endothelium-dependent vasodilation. The vasodilatory effect 
to each Ach dose was expressed as a percentage relaxation to the initial L-Phe 
precontraction. The maximal % of vasodilation was compared among rings from different 
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diet groups. The percentage of relaxation to the initial L-Phe dose of precontraction was 
used to determine the vessel sensitivity (pD ) to Ach. Enzyme expressions for NOS II 
and III were determined with western blot analyses. MnD diet resulted in depressed 
animal growth and lower hepatic Mn content. Expressions of NOS II and III were similar 
among diet groups. The addition of L-arginine did not increase NO-mediated vasodilation 
in any of the diet groups. A two-way Analysis of Variance (ANOVA) test revealed that 
the differences in the reduction of vasodilation induced by NOS inhibition with L-
NMMA were similar among diet groups. Thus, dietary Mn does not affect the availability 
of L-arginine for NO synthesis and has no effect on the expression of NOS II and III 
isoiorms. In the presence of a COX inhibitor, we observed an enhanced vasodilation of 
MnD rings, which suggests the presence of an endothelium-derived vasoconstrictor in the 
MnD group. Our results indicate that Mn affects endothelium-mediated vasodilation by 
preserving NO bioavailability and the absence of Mn from the diet might cause the 
release of an endothelium-derived vasoconstrictor. 
4.1. Introduction 
Endothelial dysfunction is defined by an impairment of vasodilator response to 
the flow of agonists, which involves multiple interacting signaling pathways. A decrease 
in the bioavailability of endothelium-derived vasodilators such as nitric oxide (NO) 
seems to be one of the primary risk factors in the development of several vascular 
diseases. Nitric oxide is synthesized by endothelial cells and has an important regulatory 
role in the cardiovascular system. Activation of specific receptors in the endothelial cell 
membrane by agonists such as Acetylcholine (Ach) results in an increase in intracellular 
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calcium which activates nitric oxide synthase (NOS) (Figures 1.2., 1.3. and 1.4.). L-
Arginine is the physiological precursor for NO formation which requires NOS, as well as 
cofactors such as tetrahydrobiopterin (BH4), flavin adenine dinucleotide (FAD), flavin 
mononucleotide (FMN), molecular oxygen and NADPH [Moncada & Higgs, 1993]. 
There are three isoforms of NOS, the neuronal NOS (nNOS or NOS I), endothelial NOS 
(eNOS or NOS III) (both NOS I and III are constitutively expressed at low levels in a 
variety of cell types) and the inducible NOS (iNOS or NOS II) which normally is not 
expressed in most cell types and is induced by bacterial endotoxin and inflammatory 
cytokines [Wu & Morris, 1998]. Reduced NO bioavailability is the result of a decreased 
production (limited substrate availability, impaired NOS activity or expression) or 
increased degradation or accelerated scavenging of NO [Arnal et al, 1999J. Under 
oxidative stress, an interaction of superoxide with NO leads to the destruction of its 
vasodilatory actions and the production of cytotoxic NO by-products such as 
peroxynitrite (ONOO). This process is related not only to reduced vasodilation but also 
to pathologic conditions such as hypertension [John et al, 20001, atherosclerosis [Russo et 
al, 2002] and diabetes [De Vriese, 2000]. 
Nitric oxide has also been shown to interfere with endothelial cell-arachidonic 
acid (AA) pathways by stimulating the activity of cyclooxygenase (COX) in the 
production of eicosanoids [Salvemini, 1996][Soma et al, 1996][Wang et al, 1997]. 
Eicosanoids are products of the AA metabolism with significant biological role in 
vascular functions. They comprise a group of endogenously produced vasoactive 
mediators with diverse roles in the regulation of vasomotor tone. Nitric oxide seems to 
regulate the synthesis of vasodilators such as prostaglandin H (PGH) and prostaglandin I2 
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(PGI2) synthase, as well as vasoconstrictors such as thromboxane A2 (TXA2). Alterations 
in the ratio between the vasoconstrictor and vasodilator eicosanoids are specifically 
important for the development of vascular dysfunction. Nitric oxide provides permanent 
negative feedback and thus, restricts the release of endothelium-derived vasoconstrictors, 
a function influenced by oxidative stress. The presence of reactive oxygen species has 
been shown to favor the production of vasoconstrictor (TXA2) instead of vasodilator 
prostanoids (PGI2) [Laemmel et a], 2003]. There is limited information on the effects of 
trace minerals and more specifically Mn, on eicosanoid metabolism in the vascular 
environment, as related to vascular function. 
Dietary manganese (Mn) has been reported to affect the vasoconstriction 
pathways by antagonizing Ca+~ ions in the endothelium, thus impairing Phe-induced 
contractions in intact rings and potentiating VSM contractions. The presence of Mn 
seems to impair the endothelial function rather than the vascular responsiveness to the 
endothelium-derived vasodilator nitric oxide (NO) (Chapter 3). The impairment in 
endothelium-dependent vasodilation is observed in dietary concentrations lower (Mn <1 
ppm) or higher (Mn 45-50 ppm) than the recommended dietary intake (MnA diet, Mn 10-
15 ppm) that is suggested by the American Institute of Nutrition [Reeves et al, 1993], 
The purpose of the present study was to determine the effect of Mn on the 
vascular ability to synthesize NO by determining: 
a. the ability of utilizing L-arginine, the substrate for NO synthesis in our diet (L-
arginine was added directly in the tissue bath to restore any reduction in dilation response 
that could be caused by a reduced availability of the substrate), 
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b. the effect of NOS inhibition on vasodilation among diet groups by using an L-
arginine analogue L-NMMA (L-A^-monomethyl arginine). L-NMMA inhibits NO 
synthesis in a dose-dependent specific manner by inducing a small but significant 
endothelium-dependent contraction and inhibits the release of NO induced by 
Acetylcholine (Ach) [Moncada et al, 1989], 
c. the expression of the two isoforms of nitric oxide synthase (NOS), the 
endothelial NOS (eNOS or NOS III) and the inducible NOS (iNOS or NOS II), 
d. the importance of the COX pathway in mediating Ach-induced vasodilation 
among diet groups, by inhibiting the activity of COX I and II with mefenamic acid 
(MFA). 
4. 2. Materials and Methods 
4.2.1. Animal Model 
Aortas from the thirty weanling male Sprague-Dawley rats (Charles River 
Laboratories, Wilmington, MA) were randomly assigned to a Mn deficient (MnD), Mn 
adequate (MnA) and Mn supplemented (MnS) diet (<lppm, 10-15ppm and 45-50 ppm of 
Mn respectively by analysis). The animals were individually housed in stainless steel cages 
in an environmentally controlled room (22°C with a 12:12 hrs light:dark cycle). Body 
weight was measured weekly. The Animal Care and Use Committee of the University of 
Maine approved all animal care and experimental procedures. 
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4.2.2. Diets 
Diets were mixed in our laboratory from purified ingredients, as described before 
[24, 25]. Vitamin (A.O.A.C. Special Vitamin Mixture, Harlan Tekland) and mineral 
mixes (ICN Biochemicals, Cleveland, OH) were commercially prepared. Manganese 
content of tap water and of the diets was determined by atomic absorption spectroscopy 
at the Maine Forest and Agriculture Experiment Station Analytical Laboratory, Plant and 
Soil Department of the University of Maine (detection limit 0.01 ppm). The rats were 
given free access to water (tap water, below the detection limit for Mn) and to one of the 
three diets for 14 weeks. 
4.2.3. Vascular Ring Studies 
At the end of the feeding period, rat food was withheld for 12-14 hrs. Animals 
were anesthetized in a chamber with 95% CO2 / 5% O2, for approximately 2 min. 
Thoracic aortas were excised and washed with PSS, with composition in mmol/L: NaCl, 
118, KC1, 4.7, NaHC03 , 25, KH2P04 , 1.18, MgS04 , 1.17, Dextrose, l l ,CaCI 2 , 1.25. 
4.2.3.1. Aortic Preparations 
The thoracic aorta was removed carefully and submerged in a petri dish filled 
with physiologic salt solution (PSS) at room temperature. The aortic segment was 
cleaned of fat and connective tissue and divided into four rings of three mm length 
prepared from the middle section of the vessel. Each ring from each animal was used for 
one of the four different treatments. Two stainless steel wire triangles (0.012 in diameter) 
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were passed carefully through each ring. Each aortic ring was mounted in a 20ml 
Radnotti tissue bath, which contained PSS maintained at 37°C by a thermoregulated 
water circuit and was continuously bubbled with a 95% O2 and 5% CO2 mixture in order 
to keep the pH at 7.4. The aortic ring was attached through the one triangle to a fixed 
glass hook in the tissue bath and through the other triangle and a weightless wire hook to 
a force transducer. The transducer was connected to a tissue force analyzer (Model 410, 
MicroMed, Louisville, KY) for the measurement of isometric force, which was 
continuously displayed and recorded on-line on a computer. 
4.2.3.2. Experimental Protocol 
A total of 64 endothelium-intact rings were used for each of the four different 
protocols, sixteen rings from each diet group. Each ring was stretched to produce a 
resting tension (preload) of 1.5g from the initiation of the experiment [28-32]. Tissues 
were washed with PSS after the application of preload and then four different treatments 
were applied to the four different rings before the preconditioning with Ach and Phe and 
the equilibration. 
One ring was washed with PSS without the addition of a substrate or an inhibitor. 
In a second ring we added PSS plus a NOS inhibitor (L-NMMA, 10"4M, inhibitor of NOS 
I, II and III) into the bath for lOmin, which remained in the tissue bath throughout the 
experiment. In a third ring a cyclo-oxygenase inhibitor (Mefenamic acid, 10 5 M, inhibitor 
of cyclo-oxygenase I and II) was added with PSS group for lOmin and remained again in 
the tissue bath throughout the experiment. In a fourth ring L-arginine (10"3M) was added 
in the tissue bath for lOmin and added back after each wash out. 
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AH rings were precontracted for lOmin with one maximal dose of L-Phe (10' M) 
and one dose of Ach (10~8 M), to saturate the non-selective receptor binding sites for the 
agonists. After washing the tissues four times the inhibitors (L-NMMA and MFA) and 
the L-arginine were added back to the tissue baths, preload was corrected to the original 
baseline levels and remained unchanged throughout the experiment. All aortic 
preparations were left to equilibrate for approximately 45min before the application of 
the dose response curve. 
Following preconditioning, all three aortic ring preparations were precontracted 
with one maximal dose of the ai adrenergic agonist L-Phe (10"6M) for lOmin, which was 
the duration necessary for the contraction curve to reach a plateau. Following the L-Phe 
precontraction, cumulative applications of seven concentrations of Ach (3 x 10" , 10" , 3 x 
10"8, 10"7, 3 x 10"7, 10"6, 3 x 10"6M) were applied. A drug-tissue contact time of six min 
was allowed for each Ach concentration to achieve the maximum relaxation to the initial 
precontraction. 
4.2.4. Western Blot Analyses ofNOS 11 and NOS III 
Aortic segments were placed under liquid nitrogen and frozen at -80°C to be used 
for determination of NOS II and NOS III expression in each animal group. Frozen aortic 
segments (O.lgm dry weight) were powdered under liquid nitrogen and placed for 30min 
on three volumes of homogenization buffer on ice [50mM Tris-HCl, 5 mM EDTA, 
lOmM benzamidine, 10% glycerol, 50ug/ml phenylmethyl sulfonyl fluoride (PMSF), 
lOug/ml aprotinin, 10u.g/ml pepstatin A and lOug/ml leupeptin (v/v) (pH 7.4-7.5)]. 
Powdered aortas were homogenized with a tissue homogenizer (Tissue Tearor, Biospec) 
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under 25rpm for 5min on ice. The homogenate was sonicated for 3min and placed on a 
rocking platform with 5% 3-[(3-chloramidopropyl) dimethylammonio]-l-
propanesulfonate (CHAPS) for 2hrs at 4°C. Following a centrifugation at 12,000g for 
30min, the supernatant was collected and total cellular protein concentration was 
determined by using the Bicinchoninic acid assay (BCA Protein Assay Kit, Pierce) with 
bovine serum albumin (BSA) as a standard. 
Protein samples 100u.g/ lane from each diet group were separated in SDS-PAGE 
electrophoresis, one for NOS II and one for NOS III determination. Human endothelial 
cell lysate (BD Transduction Laboratories) was used for a positive control for NOS III 
and mouse macrophage+IFNy/LPS (BD Transduction Laboratories) for NOS II positive 
control. High range molecular weight markers (Bio-Rad) were separated by 
electrophoresis under reducing denaturing conditions in 7.5% polyacrylamide/ SDS gels 
(Bio-Rad) (150V for 45min) and transferred by electroblotting in onto PVDF blots (100V 
for lhr and 15min at 4°C). Gels were stained with Coomasie blue stain to confirm 
complete protein transfer. 
Blots were blocked for an hour in room temperature in blocking buffer of 5% 
nonfat dry milk (Bio-Rad) in TBST-20 on a rocking plate. They were then incubated with 
the primary antibody overnight in 4°C. The primary antibody for the NOS III was the 
anti-endotheliaJ nitric oxide synthase (anti-NOS III) from BD Transduction Laboratories 
(1:1000 diluted in blocking buffer), while the primary antibody for NOS II was the anti-
inducible nitric oxide synthase antibody (anti-NOS II) from the same company (1:1000 
diluted in blocking buffer). Antibodies were diluted in 5% nonfat dry milk by adding 
20u,g of the antibody preparation in 20ml of the blocking buffer. The membranes were 
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washed 5 times with TBST-20 every 15 min and were then incubated with the same 
secondary antibody, which was a horseradish peroxidase-conjugated goat anti-rabbit IgG 
antibody (1:1000 diluted in blocking buffer, BD Transduction Laboratories) for 4hrs at 
room temperature. All membrane incubations were performed on a rocking platform. The 
membranes were washed as previously described and signal detection was facilitated 
after treatment with enhanced chemiluminescence reagents (ECL kit, Amersham). X-Ray 
films were developed for 1 min and densitometric analysis was realized on the scanned 
film images using Scion Image-Release Beta 4.02 software (http://www.scioncorp.com). 
Results were expressed as the percentage of protein staining vs. basal expression in 
positive control sample. 
4.2.5. Drugs and Chemicals 
Acetylcholine chloride, Sodium Nitroprusside, L-Phenylephrine, L-NMMA, L-
Arginine, Mefenamic acid and salts for the stock solutions of the physiologic salt solution 
(PSS: NaCl, KC1, NaHC03, KH2P04, MgS04, Dextrose, CaCl2) were purchased in pure 
forms from Sigma-Aldrich Chemical Co (St Louis, MO, U.S.A.). Reagents for SDS-
PAGE and Western blot were purchased from BioRad Laboratories, the BCA Protein 
assay kit from Pierce and the ECL Kit as well as the X-Ray ECL films from Amersham. 
Antibodies and positive controls were purchased from BD Transduction Laboratories. 
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4.2.6. Statistical Analysis 
Animal weights and hepatic Mn content were compared using a one-way analysis 
of variance (ANOVA). The relaxant effect to each Ach dose was expressed as a 
percentage relaxation to the initial L-Phe precontraction. Concentration response curves 
were fitted by nonlinear regression and EC50 and /?D2 (-log|0EC5o) were calculated. The 
pD2 values indicate the vessel sensitivity to the Ach-receptor. All results were expressed 
as mean values ± standard error of the mean (SEM). The percentages of relaxation and 
pD2 values to Ach were compared in different two-way analysis of variance (ANOVA) 
tests in order to determine the effect of different diets on vasodilation and on vessel 
sensitivity. Student Newman-Keuls tests were used for statistical analysis and a p-value 
level of 0.05 or less was considered as statistically significant. The statistical program 
used was the Sigmastat Statistical Program Package (SAS Institute, Cary, NC). Results 
from the densitometric analyses of the scanned western blot film images were expressed 
as the percentage of protein staining vs. basal expression of the positive controls. 
4.3. Results 
4.3.1. Animal Growth 
Mean body weights of MnD animals on the 14lh week were significantly lower 
than MnA weights, while rats on MnA and MnS had similar weights (Table 4.1). Liver 
weights of the MnD rats were reduced when compared to MnA; a reduction proportionate 
to the total body weight reduction. Manganese deficiency was confirmed by hepatic and 
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kidney Mn concentration, which significantly decreased only in the MnD group (Refer to 
Table 3.1, pg.58). 
The effect of Mn on Ach-induced vasodilation (Figures 4.1, 4.2, Appendix 
Figures A.l and A.2) is discussed in Chapter 3. Briefly, we observed a reduced 
vasodilation in MnD and MnS rings when compared to MnA rings and increased vessel 
sensitivity to Ach in MnS rings. Below we discuss the effect of dietary Mn on the 
enhancement or impairment of Ach-induced vasodilation by the presence of L-arginine or 
the NOS and COX inhibitors. 
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Figure 4.1. Effects of dietary Mn on Ach-induced vasodilation (expressed as % of 
Precontraction) of intact aortic rings in Sprague Dawley rat. 
MnD MnA 
Diet Groups 
MnS 
(*) Statistically significant differences atp<0.001 in comparison to MnA/ Control group. 
Figure 4.2. Effects of dietary Mn on vascular sensitivity to Ach (pD2, mean value ± 
SEM) of aortic rings in Sprague Dawley rat. 
8.6 
U 
7.4 
MnD MnA MnS 
Diet Groups 
(*) Statistically significant differences at p<0.001 in comparison to MnA/ Control group. 
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4.3.2. Effects of Dietary Mn on Vasodilation after NOSIinhibition 
L-NMMA reduced the response to Ach in all diet groups (Figure 4.3 and A.3). 
Vasodilation of the L-NMMA treated aortas from MnS animals was significantly lower 
when compared to MnD and MnA groups. The differences in reduction of vasodilation 
after treatment with L-NMMA is depicted with arrows above the bars in Figures 4.3 and 
4.4 and were not statistically different among diet groups (p=0.119) (as indicated by the 
same letters and same length of arrows in Figure 4.3). Thus, the reduction in vasodilation 
in MnS group when compared to Control (0.933 vs. 1.018), appears to be an effect of the 
reduced vasodilation in this group when the inhibitor is not present (1.249 vs. 1.374). 
The vessel sensitivity to Ach in the presence of L-NMMA was reduced in all diet 
groups on the same level, as described by similar differences in L-NMMA-induced 
decreases of J9D2 values (Figure 4.4). The reduced vessel sensitivity to Ach in MnS diet 
group in the presence of a NOS inhibitor indicates that this alteration occurs due to the 
effect of Mn on the receptor-agonist relationship (in our case on Ach and its receptor) and 
not on the decrease in synthesis/ release of NO from endothelial cells. The effect of Mn 
on enhancing vasodilation seems to be independent from NOS enzymes. Reduced vessel 
sensitivity to Ach in all groups in the presence of L-NMMA (Figure 4.4) has been 
reported in the past and is an indicator of the increased need for bound Ach in order to 
reach the same NO effect. 
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Figure 4.3. Effects of dietary Mn on the maximum Acb-induced vasodilation (expressed 
as % of Preconviction) after treatment with L-NMMA in Sprague Dawley rat aorta. 
MnD MnA 
Aortic rings treated with L-NMMA 
MnS 
(a, b) Different letters on the top of the arrows depict statistically significant differences 
on the length of the arrows, which symbolizes the reduction in Ach-induced vasodilation 
after the addition of the NOS inhibitor substrate (L-NMMA) in each individual diet 
group. 
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Figure 4.4. Effects of dietary Mn on the vascular sensitivity (pD2) to Ach after treatment 
with L-NMMA in Sprague Dawley rat aorta. 
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(a, b) Different letters on the top of the arrows depict statistically significant differences 
on the length of the arrows, which symbolizes the reduction in vessel sensitivity to Ach 
after the addition of the NOS inhibitor substrate (L-NMMA) in each individual diet 
group. 
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4.3.3. Effects of Dietary Mn on Vasodilation after in vitro Supplementation with 
L-Arginine 
Pretreatment of the rings with the NOS substrate L-arginine did not reverse the 
previously observed decreases in Ach-induced vasodilation in the MnD and MnS groups 
when they were compared to the MnA group (Figures 4.5 and A.4). The differences in 
vasodilatory response (Figures 4.5) and vessel sensitivity to Ach (Figures 4.6) appear to 
be significant, when we compare the effect of the addition of L-Arginine in each diet 
group separately (comparison of arrows in the above figures). 
However, when L-arginine is added in the tissue bath during the preconditioning/ 
equilibration stage, the percent of reduction of Ach-induced vasodilation includes the 
effect of L-arginine on the basal NO release (since L-arginine is added before the 
application of the Ach-cumulative dose response curve). That means that any decreases 
in Ach-induced vasodilation are of limited biological significance and only an increase in 
vasodilation would provide useful information for the interpretation of the effect of Mn 
on this part of the pathway. Thus, our data indicate that dietary Mn intake in the 
concentrations studied does not seem to eliminate the availability L-arginine, the 
substrate for NO synthesis. 
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Figure 4.5. Effects of dietary Mn on the maximum Ach-induced vasodilation (expressed 
as % of precontraction) after in vitro supplementation with L-Arginine in Sprague 
Dawley rat aorta. 
1.4 
1.35 
§ 1.3 
1.1 
1.374 
1.227 
< 
• 
MnD MnA MnS 
Aortic rings treated with L-Arginine 
(a, b) Different letters on the top of the arrows depict statistically significant differences 
on the length of the arrows, which symbolizes the reduction in Ach-induced vasodilation 
after the addition of the substrate (L-Arginine) in each individual diet group. 
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Figure 4.6. Effects of dietary Mn on the vascular sensitivity (JJDT) to Ach after treatment 
with NO substrate (L-Arginine) in Sprague Dawley rat aorta. 
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Aortic rings treated with L-Arginine 
MnS 
(a, b) Different letters on the top of the arrows depict statistically significant differences 
on the length of the arrows, which symbolizes the reduction in vessel sensitivity to Ach 
after the addition of the substrate (L-Arginine) in each individual diet group. 
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4.3.4. Effects of Dietary Mn on COX Pathway 
In MnD animals treated with the COX inhibitor MFA we observed an increased 
response to Ach-induced vasodilation, when compared to rings with no inhibitor from the 
same diet group (1.347 vs. 1.280) (Figure 4.7 and A.5). In the presence of MFA, vessel 
sensitivity of MnS rings to Ach was similar to that of the Control group (8.334 vs. 8.323), 
while MnD vessel sensitivity was significantly increased (8.426 vs. 8.323) (Figure 4.8). 
When compared to the rings in which there was no inhibitor added, the presence of MFA 
increased the vessel sensitivity to Ach in MnD and MnS rings but not in the MnA rings 
(depicted by arrows a and b in Figure 4.8). The enhancement of vasodilation after the 
addition of MFA (Figure 4.8) was significantly higher in MnD and MnS animals when 
compared to Controls (small decrease was observed). The addition of MFA increased 
vasodilation in MnD group thus, the presence of Mn deficiency seems to affect COX-
mediated vasoactive component(s) which function(s) as endothelium-derived 
vasoconstrictor(s). The increased vessel sensitivity to Ach in MnS group does not appear 
to affect vasodilation (maximum % of vasodilation). Therefore, even though there is an 
indication for the production of an endothelium-derived vasoconstrictor in MnS animals, 
this effect might be masked or impaired probably due to the enhanced VSM pre-
contraction in these rings (refer to chapter 2) and our observations are limited to provide 
an interpretation of the above findings. 
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Figure 4.7. Effects of dietary Mn on the maximum Ach-induced vasodilation (% 
Precontraction) after treatment with cyclooxygenase inhibitor (MFA) in Sprague Dawley 
rat. 
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(a, b) Different letters on the top of the arrows depict statistically significant differences 
on the length of the arrows, which symbolizes the reduction in Ach-induced vasodilation 
after the addition of the cyclooxygenase inhibitor (MFA) in each individual diet group. 
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Figure 4.8. Effects of dietary Mn on the vascular sensitivity O0D2) to Ach after treatment 
with cyclooxygenase inhibitor (MFA) in Sprague Dawley rat. 
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(a, b) Different letters on the top of the arrows depict statistically significant differences 
on the length of the arrows, which symbolizes the reduction in vessel sensitivity in Ach 
after the addition of the cyclooxygenase inhibitor (MFA) in each individual diet group. 
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4.3.5. Effects of Mn on NOS Expression 
Determination of NOS expression allows us to detect whether the effect of dietary 
Mn on vasodilation is on the expression of one or both of NOS isoforms or if it acts at 
some point downstream to decrease NO production or bioactivity/ bioavailability. 
Quantification of the staining of each blot on the scanned film images was obtained by 
estimating the % of absorbance in each blot compared to the positive control blot (mouse 
macrophage+IFNy/LPS for NOS II and human endothelial cell lysate for NOS III) that 
was used in each transfer. The increased variability among diet groups did not allow us to 
compare the statistical significance of the findings, however, we did not observe any 
differences in the NOS II nor NOS III expression among diet groups as appears in Figure 
4.9a and 4.9b. 
Figure 4.9. Two representative western blot determinations of the relative amounts of 
NOS III (a) and NOS II (b) among diet groups. 
Human 
endothelial cell
 M n D M n A M n S 
lysate0 
I ^ 
a. NOS III
 ( 
140 kD 
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macrophage*
 M n D M n A M n S 
IFNy/LPSc 
I I I NOSH 
130 kD 
c
 Human endothelial cell lysate was used as a standard (positive control) for NOS III and 
mouse macrophage + IFNy/ LPS as a standard for NOS II. 
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4.4. Discussion 
Manganese deficiency was confirmed by the suppression of animal growth in the 
MnD diet group, as well as by the lower hepatic Mn content (Table 4.1). Retardation of 
rodent growth in Mn deficiency is an effect of reduced efficiency of food conversion with 
the dietary Mn depletion and has been reported in the past [Yang et al, 19981 [Yang e t al, 
1998b] [Kalea et al, 2005][Taylor et al, 1997][Klimis-Tavantzis et al, 1993][Yang et al. 
1998|[Yang et al, 1998b][Paynter, 1980][Fahim et al, 1990][Malecki et al, 1994]. The 
decrease in liver weight in MnD rats was proportional to the decrease in body weight in 
MnD animals (Table 4.1). Hepatic Mn concentration in liver was significantly reduced in 
the MnD diet group when compared to MnA/ Control, while there were no differences 
between MnA and MnS animals (Table 4.1). 
We document for the first time that the effect of dietary Mn on endothelium-
dependent vasodilation of the rat aortic vessel is independent of the NOS expression and 
NO synthesis. The reduced vasodilation observed in MnD and MnS animals when 
compared to Controls is not an effect of substrate availability or expression of NOS. 
Altering the Mn from control levels in the experimental diets in both directions (Mn 
deficiency and Mn supplementation) modified vasodilation in response to Ach, which 
was affected by the presence of endothelium. In MnD diet we observed a potentiation of 
vasodilation to Ach with the presence of a COX inhibitor (MFA), which is an indication 
of synthesis of a COX-dependent endothelium-derived contracting factor in aortas of 
MnD animals. In MnS animals vessel sensitivity to Ach was increased when COX was 
inhibited, however that had no effect on the maximum vasodilation. 
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There have been several reports that COX inhibition increases the response to 
Ach in hypertensive patients while it has no effect on Ach-induced vasodilation in norma] 
patients [Laemmel et al, 20031 and that COX derivatives can curtail endothelial responses 
in essential hypertension [Taddei et al, 1997]. In spontaneously hypertensive rats, an 
impairment of endothelium dependent relaxation was associated with an increased release 
of TXA2, a vasoconstrictor eicosanoid underlying the endothelial cell dysfunction in 
hypertension [Kato et al, 1990]. 
It has been recently reported that dietary Mn does not affect the expression of 
NOS III in rat aorta when the latter was estimated by immunohistochemical analyses. 
[Ensunsa et al, 2004J. Comparisons were conducted only between MnD and MnS (MnS 
was the Control group in the study of Ensunsa et al, 2004). There have been no studies to 
date on the NOS II expression in different dietary intakes of Mn, nor on the activity of the 
two isoforms. We know that possible changes in activity of NOS II and III are 
independent of the expression of the two enzymes. NOS III activity is markedly inhibited 
by NO itself, while NOS II is resistant to NO inhibition. Thus, even if we were able to 
observe changes in enzyme expressions in our study, we could not assume that this has an 
effect on their activity in the same groups. At sites of endothelial damage, locally 
released cytokines stimulate iNOS expression and activity in the vascular wall and the 
NO produced reduces eNOS activity even though the expression of the enzyme might be 
similar or higher [Cernadas et al, 1998]. 
Manganese due to its role as an essential cofactor for manganese superoxide 
dismutase (MnSOD) is considered to be one of the important antioxidant defense 
mechanisms in the cellular environment [Zidenberg-Cherr, 1983]. Deficiency of Mn is 
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known to reduce the activity of MnSOD in liver, heart and kidney, allowing the 
formation of superoxide [Ensunsa et al, 2004][Ma)ecki et al, 1994][Malecki et al, 
1996|[Paynter DI, 1980]. This deleterious free radical reacts with and inactivates NO. An 
increase in formation of NO by-products such as peroxynitrite (ONOO-), nitrite (NO2) 
and nitrate (NOi) is an indication of NO inactivation. Superoxide dismutase has been 
shown to potentiate the effects of the release of basal [Rubanyi & Vanhoutte, 19861 and 
Ach-induced NO-dependent relaxation in arterial rings [Mian & Martin, 1995], with 
basal NO activity being more sensitive to inactivation by superoxide anion than Ach-
stimulated activity [Mian & Martin, 19951. The accumulation of reactive oxygen species 
in the case of reduced activity of MnSOD, might have profound effects on the production 
of eicosanoids through the COX pathway, as has been shown in the past for other trace 
mineral deficiencies such as selenium (Se) [Weaver et al, 2001]. Bovine aortic 
endothelial cells have been reported to produce higher TXA2 (vasoconstrictor) and lower 
PGL (vasodilator) in Se deficiency, which has been associated with aging but most 
importantly is a pathological indicator in children and adolescents with a predisposition 
in coronary heart disease [Mihai et al, 1992][Akimova et al, 1994], 
Our data suggest that Mn deficiency appears to shift the balance of endothelium-
derived eicosanoids by leading to a release of an endothelium-derived vasoconstrictor, 
possibly TXA?. This finding suggests that Mn deficiency might have a profound effect in 
the elderly as well as in populations that are prone to cardiovascular disease. Even though 
there is limited information on the mechanisms underlying the modifications in 
eicosanoid pathway by the presence of dietary Mn, we do know that patients with 
congestive heart failure due to ischemic heart disease or cardiomyopathy have 82.8% 
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insufficient intake of dietary Mn [Gorelik et al, 2003] while patients with atherosclerosis 
appear to have decreased concentrations of Mn in aorta, liver, myocardium, adrenal 
glands, pancreas and kidney when compared to healthy individuals [Volvkov, 1962]. The 
presence of Mn might modulate the synthesis or activity of key enzymes in the 
complicated COX pathway. In Se deficiency the activity of PGI2 synthase is 
downregulated by the increased oxidative stress, which might be the case in Mn 
deficiency as well [Weaver et al, 2001]. 
The product of the antioxidant effect of Mn+2 is Mn+3, which might form Mn+4 
and Mn+2 in the presence of water and subsequently a two-electron oxidation by Mn+5 
might take place [Coassin et al, 1992]. Formation of Mn in higher oxidation states 
accounts for the pro-oxidant role of Mn that might lead to an increased oxidative stress 
state, even though the 45-50 ppm are far from the toxic Mn levels (~1000ppm). A small 
increase in oxidative stress in MnS diets might explain the increased vessel sensitivity of 
MnS aortas to Ach in the presence of MFA. Such an increase might be an indication of 
the presence of an endothelium-mediated vasoconstrictor such as TXA2, whose effect on 
inhibiting maximum vasodilation in possibly blunted by the increased VSM constriction 
observed in MnS rings (Chapter 2). 
Dietary Mn seems to affect endothelium-mediated vasodilation both in deficiency 
and supplementation states. Even though this effect is independent of NO synthesis and 
generation, it is possible that it affects the bioavailability of NO in downstream 
endothelial pathways. The presence of oxidative stress in Mn deficiency due to the 
reduced activity of the major antioxidant enzyme MnSOD might reduce vasodilation by 
affecting the degradation of NO after it is produced or by enhancing the production of 
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endothelium-derived vasoconstrictors such as TXA2, with the concomitant inhibition of 
endothelium-derived vasodilators such as PGI2. The findings provide further information 
on the effects of Mn deficiency on oxidative stress and vascular dysfunction. 
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Chapter 5 
Summary and Conclusions 
Manganese is a multifunctional trace element involved in a plethora of metabolic 
pathways. It is a cofactor for enzymes such as MnSOD, arginase, glycosyltransferases 
and sulfonases and it has been reported to antagonize or substitute for several divalent 
ions in the cellular environment. Thus, Mn may be crucial in the modulation cellular 
functions that regulate vascular tone. 
5.1. Manganese and Vasoconstriction 
We document for the first time that the presence of Mn in the diet affects the ot| 
adrenergic agonist-induced contractions of the rat aortic vessel. This trace element seems 
to affect both the maximal contractile response of the aorta to Phe and the membrane-
related receptor sensitivity. Supplementation of Mn in 45-50 ppm, which is far from the 
toxic levels, did not affect the sensitivity of the adrenergic receptors in the endothelial 
and VSM cells, even though it significantly increased the VSM constriction. In Mn 
deficiency, we observed an increase in adrenergic receptor sensitivity (higher pD2) when 
the endothelium was present, when compared to the control diet group, which did not 
affect the responsiveness of the contractile machinery (Fmax). The hypocontractility of 
intact rings from MnS group was attributed in part to the increased basal vasodilator tone 
of the endothelial cell layer, which balances the increased constriction of the vascular 
smooth muscle (as observed in disrupted rings). We concluded that Mn affects 
endothelial cells blunting the enhancement of Phe-induced vasoconstriction caused by the 
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presence of Mn in VSM. The enhanced effect or role of Mn on the contractile efficiency 
of the VSM is not on the receptor level but rather on the contractile machinery. 
In our study we also examined vascular responsiveness to adrenergic stimulation 
of animals fed diets with different concentrations of Mn. We examined the ay adrenergic 
receptor mediated vasoconstriction using L-Phe, a synthetic catecholamine that causes 
VSM contraction by stimulating the release of calcium from intracellular stores. We 
hypothesized that the presence of Mn in the diet inhibits the vascular contractions 
induced by antagonizing Ca+~ in the agonist-induced vasoconstriction [Liu et al., 
2002] [Yan et al., 1998][Yan et al., 2001][Salaices et al., 1983][Kuribayashi. 
L969|[Sullivan et al., 1968]. Our findings are supported by similar in vitro observations 
on the effect of different concentrations of Mn on adrenergic receptor stimulated 
vasoconstriction in porcine coronary artery, goat and human cerebral arteries as well as 
rat aorta |Yan et al., l998]|Yan et al., 2001]. Manganese can pass through voltage-
dependent Ca+2 channels and might share a Ca+ -blocking property in smooth muscle 
cells by antagonizing Ca+ and preventing its binding to calmodulin for the activation of 
NOS and the basal production of NO. Finally, the enhancement in maximum VSM 
constriction in the MnS diet group when compared to control indicates that the presence 
of Mn enhances the efficiency of the contractile machinery in the VSM and could imply 
an effect of the trace element on the cross bridge formation of the smooth muscle. 
In our study we did not observe any differences in vasoconstriction of MnD rings 
when compared to control rings (MnA), even though there was an increased vascular 
sensitivity to the adrenergic agonist (higher pD2 of intact MnD rings but not of 
disrupted). However, we did observe a decreased constriction of the VSM in 
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endothelium-disrupted MnD rings only, when compared to the control group, which was 
independent of the vascular smooth muscle cell sensitivity. This may suggest an impaired 
ability of the endothelial cell in MnD animals to synthesize vasodilators or protect their 
integrity in order to counterbalance vasoconstriction, which may be explained by the 
increased oxidative stress and decreased NO bioavailability in case of Mn deficiency. 
Our results demonstrate, for the first time, that dietary Mn is implicated in the 
vascular contractile model, affecting the mechanical properties of blood vessels in 
response to an adrenergic stimulus, which implies alterations in regulation of vascular 
tone. The effects of Mn depend on its concentration in the diet and on the presence of a 
viable endothelium. 
5.2. Manganese and Vasodilation 
We documented that the presence of Mn in the diet affects the function of the 
endothelial layer since we did observe significant differences among diet groups 
primarily in endothelium-dependent vasodilation (induced by Ach). The alterations 
observed in endothelium-independent vasodilation as induced by a direct smooth muscle 
relaxant (SNP) were of small biological significance (Chapter 3). Mn deficiency seems to 
reduce the production and/or bioactivity of endothelium-generated vasodilators, without 
affecting membrane-related events. Dietary Mn has no effect on enzyme (NOS) 
expression nor substrate (L-arginine) availability that would regulate NO formation. Our 
findings are in accordance with previous determinations of NOS III expression in 
different dietary intakes of Mn. However, we can not exclude the possibility that dietary 
Mn might affect the bioavailability of NO after it is produced (basal or receptor-
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stimulated NO release). Manganese is known to affect the synthesis of metalloenzymes 
such as MnSOD that protects the cell membrane structure from free radicals (O " 
generation) generated by cellular respiration [Malecki et al., 1994] [Ensunsa et a!., 2004] 
IZanetti et al., 2001][Wambi-Kiesse et al., 1999]. It is now known that oxidative stress 
initiates endothelial dysfunction by affecting the production of endothelium-derived 
vasoactive mediators [Gao et al., 1994][Williams et al., 1998]["Matsuoka, 2001]. 
Decreased bioavailability of endothelial-released NO due to its increased degradation by 
superoxide affects the biomechanical properties of the contractile machinery. 
Manganese is also a metalloenzyme for arginase, the enzyme that catalyzes the 
formation of L-ornithine for L-arginine, competing for the same substrate (L-arginine) 
with NOS III which catalyzes the formation of L-citrulline from L-arginine with the 
subsequent production of NO. Mn deficiency has been reported to affect arginase activity 
and also NO production and/or bioavailability. A competition between arginase and 
endothelial NOS has been suggested as a novel mechanism for atherosclerotic endothelial 
dysfunction [Ming et al., 2004]. There are no studies to our knowledge on the arginase 
activity in vascular wall in Mn deficient rats. A reduced activity of arginase in aortic 
endothelial cells of MnD animals would enhance NOS activity in order to form more NO 
from L-arginine. However, our data indicate that dietary Mn does not seem to affect the 
synthesis of NO from L-arginine, which could be attributed to a less severe induction of 
Mn deficiency in our experiments (compared to Mn deficiency induced in offsprings of 
MnD rats). 
When Mn is present in levels of supplementation (MnS) we observed a decrease 
in vessel sensitivity to Ach. Such a finding suggests an effect of dietary Mn on the 
99 
relationship between Ach and the membrane receptor of the agonist or a decrease in the 
release of NO from endothelial cells due to increased degradation of NO attributed to the 
pro-oxidant nature of the trace mineral. It has been well documented in the past that 
dietary Mn affects the concentration and synthesis of proteoglycan and 
gjycosaminoglycan (GAG) structures in rat aorta, which interact in divergent ways with 
biologically effective molecules, such as receptors, enzymes, cytokines, growth factors 
and proteins [Yang et al., l998][Yang et al., 1998b][Klimis-Tavantzis et a!., 1989] 
[Wight et al., 1992]. Sulfonation is the recognized primary mechanism that influences 
biological activity by determining high specificity in these receptor-ligand binding 
interactions [Strott, 2002][Lyon et al., 1998]. Overexpression of HSPGs appears to 
enhance vascular sensitivity to agonists, an indicator of the binding affinity of the ligand 
with the specific receptor, especially in low ligand concentrations [Risler et al., 
2002][Kramer et al., 2003]. We observed a decrease in the sulfation of HS disaccharides 
in MnS aortas [Kalea el al, 2004]. This has been related to a downregulation of gene 
expression and clustering (aggregation) of Ach receptors in vitro [Meier et al., 
1998][Jones et al., 1996j[McDonnel et al., 2004] and could explain the decreased vessel 
sensitivity to Ach in MnS animals, provided that we do have maximum receptor 
occupancy in our experimental conditions. 
Ensunsa et al. [Ensunsa et al., 2004] recently reported a decreased vascular 
reactivity to Ach in aortic rings from rats fed a MnS diet, while they did not observe any 
statistically significant differences to SNP-induced vasodilation. In their experimental 
protocol they used MnD female offspring of MnD Sprague Dawley rats and compared 
them with MnS-fed rats (45 ppm) without using a MnA/ Control diet group. Our results 
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are in accordance with the findings of this study (reduced Fmax and pD2 in MnS group 
when compared to MnD) [Ensunsa el al., 2004], 
Altering the Mn from control levels in the experimental diets in both directions 
(Mn deficiency and Mn supplementation) modified vasodilation in response to Ach. This 
was affected by the presence of endothelium. In Mn deficiency the presence of a COX 
inhibitor potentiated vasodilation in response to Ach, which is an indication of synthesis 
of a COX-dependent endothelium-derived contracting factor in aortas of MnD animals 
possibly of TXA2. Oxidative stress in the presence of a reduced MnSOD activity has 
been shown to affect the production of eicosanoids through the COX pathway. This has 
been documented in the past for other trace mineral deficiencies such as selenium (Se) 
[Weaver et al., 2001 j . Increased production of endothelium-derived vasoconstrictors such 
as TXA2 and decreased formation of endothelium-derived vasodilators such as lower 
PGI2 (vasodilator) is common in elderly and is a pathological indicator in children and 
adolescents with a predisposition in coronary heart disease [Mihai et al., 1992|[Akimova 
et al., 1994]. Thus, correction of a Mn deficiency in the elderly as well as in populations 
that are prone to cardiovascular disease is of extreme importance. The mechanisms 
underlying the modifications in eicosanoid pathway by the presence of dietary Mn are 
unknown and might depend on the role of Mn as a cofactor for enzyme systems that may 
participate in the complicated COX pathway. The role of Mn as a pro-oxidant may 
explain the possible release of an endothelium-mediated vasoconstrictor in MnS rings, 
whose effect seems to induce borderline changes in vasodilation or may be masked by the 
increased VSM constriction observed in MnS rings. 
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Dietary Mn seems to affect endothelium-mediated vasodilation both in deficiency 
and supplemented states. Even though this effect is independent of NO synthesis and 
generation, it is possible that it affects the bioavailability of NO in downstream 
endothelial pathways. The presence of oxidative stress in Mn deficiency due to the 
reduced activity of the major antioxidant enzyme MnSOD might decrease vasodilation by 
affecting the degradation of NO after it is produced. Additionally, it may enhance the 
production of endothelium-derived vasoconstrictors such as TXA2., with the concomitant 
inhibition of endothelium-derived vasodilators such as PGI2. These findings provide 
further information on the effects of Mn deficiency on oxidative stress and vascular 
dysfunction and are in agreement with all previous investigator's results, complementing 
the available information on the effect of different dietary Mn intakes. 
5.3. Limitations and Recommendations for Future Work 
Our studies concluded that Mn has an effect on endothelium-mediated 
vasodilation, which depends on the Mn intake in the diet. The presence of the trace 
element dose not affect the synthesis and generation of NO in the vascular cell nor the 
cGMP pathway in the VSM cells, since all diet groups had the same response to NO 
donors (SNP). Our data could not exclude the possibility of a reduced vasodilatory role of 
the endothelium at least in Mn deficiency. A reduced NO bioavailability may be a result 
of decreased formation or increased degradation of the diffusible vasodilator. In our study 
we described the effect of Mn intakes on NO generation. Further studies on the 
concentration of NO by-products such as ONOO-, N02 and N03 are necessary in order 
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to detect possible increase in NO degradation due to oxidative stress, which seems to 
describe a Mn deficiency condition. 
Manganese seems to affect the gene expression or activation (clustering or 
phosphorylation) of the receptors that were used in our experiments. This seems to be 
mediated by the effect of Mn on glycosaminoglycan concentration and structure, which 
participate in receptor structures in order to facilitate the ligand-receptor binding. It 
would be interesting to study in the future whether the presence of Mn in the diet affects 
the receptor molecules and the glycosaminoglycan-receptor binding capacities. 
Additionally, since dietary Mn intake may modulate EC gene expression, it would 
be interesting to study the effect of the different diets on the expression of one or more 
"atheroprotective genes" in EC, such as MnSOD, COX-II and NOS III, whose 
antioxidant, antithrombotic, and antiadhesive properties are consistent with a protective 
role in the atherosclerotic disease. 
The deficiency induced in our study by elimination of dietary Mn from food and 
water can not be considered a severe deficiency. It is interesting to note that Mn 
deficiency at <1 ppm in weanling animals for a short time period affects vascular 
responses to agonists. Although deficient Mn status in humans is rare, subclinical Mn 
deficiency in humans has been noted [Pennington et al., 1991] and it usually underlines 
several pathologic conditions [Volvkov, 1962][Gorelik et al, 2003]. Our findings indicate 
that in Mn deficiency we have a production of endothelium-derived vasoconstrictor 
prostanoids, and a decrease in endothelium-derived vasodilators suggesting that an 
underlying deficiency of the trace mineral may exacerbate the clinical profile of the 
above diseases. 
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Manganese is a multifunctional trace element participating in many fundamental 
processes in the cell [Korc M, 1993]. Its effect on the vascular system, such as the control 
of vasomotor tone and blood pressure regulation still remains to be unraveled. Our results 
demonstrate, for the first time, that dietary Mn affects different pathways that regulate the 
functional properties of the rat aorta, which might be significant for populations with 
predisposition to cardiovascular diseases. This effect depends on its concentration in the 
diet and on the presence of a viable endothelium. The adequate dietary intake of Mn as 
suggested by AIN (10-15 ppm) seems to be the optimum dietary intake for growth as 
well as for normal vascular function. However, the effect of different dietary Mn 
concentrations between 10 ppm and 45 ppm (which has been used in literature as a 
control group) on vascular function and arterial functional properties need to be 
evaluated. 
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